Cancer Incidence in Oman 2010

Cancer Incidence in Oman
Report of 2010
Cancer Incidence in Oman

Report of 2010
Prepared by
Ali J Mohammed, MD
Jawad A Al-Lawati, MD
Najla A Al-Lawati, MD
Nabil H Al-Siyabi
Dhahi O Al-Gharbi
Email : mohdncd@gmail.com
Preface
I am pleased to foreword the 15th annual report of Cancer Incidence in Oman for the year 2010
coinciding with the meeting of the Council of Health Ministers of the Gulf Cooperation Council.
According to WHO, cancer is a leading cause of death worldwide and accounted for 7.6 million
deaths (around 13% of all deaths) in 2008 and are projected to continue to rise to over 11 million
in 2030. It can be reduced and controlled by implementing evidence-based strategies for cancer
prevention, early detection of cancer and management of patients with cancer. In Oman over the
past few years it ranked as the third leading cause of in-patient mortality.
This report conrms previous ndings that cancer is not yet a major public health problem in Oman,
as age adjusted incidence rates in Oman appear to be one of the lowest in comparison to industrialized countries. Although breast cancer incidence is on increase over the past few years, it remains
low compare to other GCC countries, as reported by the recent GCC report publication1. As an
example in Bahrain, the age adjusted incidence rate of breast cancer was reported to be 54.4 per
100,000 population compare to 15.7 in Oman,
I would like to thanks all colleagues working in various institutions for their cooperation in notifying
cancer cases to the National Registry. I hope this report will be able to stimulate the reading of clinician, researcher, administrators and those interested in this led. We welcome suggestions and
comments on this report in order to improve the quality of cancer registration in Oman.
Dr. Ali Jaffer Mohammed

Chairperson, National Cancer Control Committee
Advisor of Health Affairs
1 Ten Year Cancer Incidence Among Nationals of the GCC States 1998-2007
Dr. Qasim Al Salmi

Dr. Bassim Al-Bahrani
Dr. Fatima Ramadan
Dr. Zahid Al Mantheri
Dr. Taha Al-Lawati
Dr. Najwa Al Banna
Dr. Eileen Tomas
Dr. Sosamma Thomas
Dr. Usha Sharma
Mr. C.B.Bhat
Mr. Haitham Makki
Mrs.Faiza Al Balushi
Dr. Ali Al Maashani

Dr. Hunain Al-Kindi
Ms. Shaika Al-Masoudi
Mr. Fedamani Sathyaseelan
Mr. Saud Al Balushi
Dr. Mohammed Al-Balushi

Dr. Mohammed Issa Al-Ismaili
Mr. Ibrahim Al-Selami
Mr. Essa Al Kalbani
Dr. Adil Al Ansari

Dr. Ali Al-Madhani
Dr. Ashraf fauzi
Dr. Varna Menon
S/N Naima Awadh
Ms. Fatima Rashid
Mr. Sami Al-Baloushi
Mr. Adil Al Khawaldi
Mr. Ouf Khan
Dr. Ali Al Adhawi

S/N. Salem Saud Al Dhawi
Mr. Salim Al Harthy
Dr. Mohammed Al-Farsi

Mr. Othman Al-Rasbi
Dr. Mohd. Yahya
Ms. Mariam Al-Araimi
Mrs. Ayesha Al Hashmi
Dr. Salim Al Abri

Dr. Abdul Salaam Abdul Rahman
Dr. Abubaker Al Sadiq
Mr. Hilal Ambusaidi
Dr. Jawahir Al Yazidi

Dr. Khalid Al Shihi
Mr.Amer Al Aisry
S/N. Khaleefa Al-Zeedi
Dr. John Idicula

Dr. Ahmed Nada
S/N. Badr Al Hatmi
S/N. Nasser Shanin
Mr. Abdul Rahman Al Hadhrami
Dr. Abdul Rahman Saifudeen

Dr. G. Rajasekharan
Mr. Shanker
S/N.Mariam Saeed Al-Noobi
Dr. Ahmed Al Mandhari

Dr. Mansour Al Manthari
Dr. Akram Fawda
Dr. Zakia Al-Lamki
Dr. David Dennison
Dr. Aisha Al Hamadani
Dr. Ibrahim Al Haddabi
Mr. Salim Al Wahaibi
Mr. Saif Al-Raqadi
Mr. Hamed Al Ghaithi
Mr. Leonard brown
Mr. Stuart Donaldson
Mr. Rod Villcrucis
Mr. Yousif Al Falahi
Ms. Basma Al Raeisi
Ms. Nadheera
Mr. Mohammed Al Maawali

Mr. Mahmood Al Duwaibi
Dr. Aqeed Ali Al Harthi

Dr. Moqaddam Sameer Sayyed
Dr. Raid Masood Al kindi
Mr. Kamal Ahmed
Mr. Al Aqied Sultan Yarub Al-Bus

Dr. Mathew Koshy
Dr. Chakravarthy
Mr. Abdulla Al-Alawi
Dr. Jolly Philip

Dr. Maria Aamir
Dr. Jerard Strong

Mr. Salem Al Shukaily
Mrs. Nadia Al-Salmani
Mr. Essa Al Jabri
Dr. Imam A.Imam
Ms. Jokha Al Rashdi

Mr. Zayed Siyabi
9
9
9
13
13
13
14
14
14
15
1998-2010
17
22
23
28
29
34
36
40
42
44
46
48
50
52
54
56
58
60
62
64
66
68
70
72
74
76
78
81
89
97
100
www.moh.gov.om
Background
Background Of The Sultanate Of Oman
the coastal areas in summer, hot and dry
Geographical Features
in the interior with the exception of higher
The Sultanate of Oman is located in
mountains and Dhofar Governorate, which
the southeastern corner of the Arabian
enjoy a moderate climate throughout the
Peninsula. It has a coastal line extending
year.
almost 1,700 kilometers from the Strait

of Hormuz in the north to the borders of
The Sultanate of Oman is administratively
the Republic of Yemen, overlooking three
divided into 9 Governorates/ Regions with
seas; the Arabian Gulf, Gulf of Oman and
61 Wilayah. These are: Muscat, Dhofar,
the Arabian Sea.
The country borders
Musandam and Buraimi Governorates
Saudi Arabia and United Arab Emirates
and regions of Ad Dakhliyah, Sharqiyah,
(UAE) in the west, the Republic of Yemen
Batinah, Adh Dhahirah, and Al Wusta. The
in the south, the Strait of Hormuz in the
regions of Sharqiyah and Batinah have
north and the Arabian Sea in the east.
each been further subdivided into two,
Besides, there are a number of scattered
for the purpose of health administration,
Omani islands in the Arabian Sea; the most
giving a total of ten health regions.
important are Masirah and Al-Halaniyat.

The total area of the Sultanate of Oman is
Population Structure
approximately 309,500 square kilometers
The estimated mid-year population in 2010
and it is the second largest country in
was 2,749,734 of which 1,933,591 were
the Arabian Peninsula. The Sultanate is
Omanis and 816,143 were Non-Omanis
composed of varying topographic areas
(Table 1). The Omani population shows a
consisting of plains, wadis (dry river beds)
sex ratio of 975 females per 1000 males.
and mountains. The most important area
About 13.46% of the population is under-5
is the plain overlooking the Gulf of Oman
years and 35.28% is under-15 years. Only
and the Arabian Sea with an area of about
5.17% of the total Omani population is
3% of the total area. The mountain ranges
above the age of 60 years.
occupy almost 15% of the total land of

Oman and are inhabited by about 5% of
Table 2 gives the population distribution
the population. The remaining area is
of Omanis by region and gender, which
mainly sand, wadis and desert (about 82%
was used to calculate incidence rates for
of the total area). The climate differs from
different regions.
one area to another; it is hot and humid in

www.moh.gov.om
Background
Table 1: Age Structure of the Omani Population, 2010

Age
Group
Male
Number
Female
Number
04
59
10 14
15 19
20 24
25 29
30 34
35 39
40 44
45 49
50 54
55 59
60 64
65 69
70 74
75 +
Total
Total
Number
132,908
107,418
107,667
123,606
121,726
102,246
75,182
50,742
36,104
28,871
24,282
16,968
16,147
11,537
11,084
12,085
13.58
10.98
11.00
12.63
12.44
10.45
7.68
5.19
3.69
2.95
2.48
1.73
1.65
1.18
1.13
1.24
127,423
103,849
103,056
117,382
115,848
101,433
75,806
49,461
36,025
29,717
27,205
18,747
15,923
10,916
9,484
12,743
13.34
10.87
10.79
12.29
12.13
10.62
7.94
5.18
3.77
3.11
2.85
1.96
1.67
1.14
0.99
1.34
260,331
211,267
210,723
240,988
237,574
203,679
150,988
100,203
72,129
58,588
51,487
35,715
32,070
22,453
20,568
24,828
13.46
10.93
10.90
12.46
12.29
10.53
7.81
5.18
3.73
3.03
2.66
1.85
1.66
1.16
1.06
1.28
978,573
100.00
955,018
100.00 1,933,591
100.00
Table 2: Population Distribution of Omanis by Regions and Gender, 2010

Region
Males
Females
Total
Al Wusta
9,636
9,181
18,817
Ad Dakhliyah
132,818
133,395
265,805
Adh Dhahirah
81,135
78,809
159,944
Dhofar
83,003
79,080
162,083
Musandam
11,272
10,361
21,633
Muscat
206,523
195,543
402,066
North Al Batinah
192,722
189,120
381,842
North Ash Sharqiyah
67,077
67,382
134,459
South Al Batinah
116,876
114,693
231,569
South Ash Sharqiyah
77,511
77,862
155,373
978,573
955,018
1,933,591
Total
www.moh.gov.om
10
Background
11,084
12,085
10,916
9,484
12,743
Population Pyramid, Oman, 2010
11,537
15,923
49,461
16,147
50,742
75,806
18,747
75,182
101,433
16,968
102,246
115,848
27,205
121,726
117,382
24,282
123,606
103,056
29,717
107,667
103,849
28,871
107,418
127,423
36,025
132,908
955,018
36,104
978,573
11
www.moh.gov.om
Background
Health Administrative Regions of The Sultanate of Oman
This diagram is not an authority on international boundaries

Administrative boundaries for Al-Buraimi not shown.
www.moh.gov.om
12
Registry Methods
Oman National Cancer Registry

The Oman National Cancer Registry was
established in 1985 as a hospital based
registry. Only cases treated in tertiary
hospitals were registered. In 1996, with the
establishment of the Department of NonCommunicable Diseases Surveillance
and Control, the cancer registry was
transferred and started functioning under
the Directorate General of Health Affairs.
New cancer notication forms were
developed and distributed to all regional
hospitals and sister institutions. In the year
2000, the registration form was simplied
(see annex 2), printed and distributed to
all institutions that could potentially report
cancer cases. Two trained cancer registrars
are responsible for data collection, coding
and data entry.
personnel visiting different sources and

abstracting data on Cancer Registry
Forms. Being the largest tertiary centre
for diagnosis and treatment of cancer,
registrars visit the Royal Hospital twice a
week and abstract data on the notication
forms. Similarly, other tertiary hospitals like
Khoula Hospital and Al-Nahda Hospital are
visited once a month.
A new National Oncology Centre was
established in the Royal Hospital in
November 2004 after which data is also
collected in the form of chemotherapy and
radiotherapy lists.
Patients diagnosed abroad are traced
through the Oncology Outpatient Register
at the Royal Hospital and subsequently
data are extracted from their case notes.
Details of patients treated abroad are
obtained from the Department of Treatment
Abroad, Ministry of Health.
Objective of Cancer Registry

1. To compile an accurate database on the
incident cases of cancer in The Sultanate
of Oman.
2.To monitor the trends of cancer which
can guide policy makers in setting priorities
for control and management of cancer.
3.To provide researchers and clinicians
with population based information on the
number and types of cancer cases and
their geographical distribution within the
Sultanate of Oman
b) Passive Reporting
Cancer notication was made mandatory
in the year 2001 through a Ministerial
Decision (4/2001). When a case of cancer
is diagnosed, the attending physician
of the relevant specialty or the medical
records department at the regional hospital
completes the notication forms and sends
them to the registry. Other institutions like
the Armed Forces Hospital and Sultan
Qaboos University Hospital do similar
passive reporting.
Methods
1. Data Collection
a) Active Collection
Active collection involves the registry
www.moh.gov.om
13
Registry Methods
2. Data-Coding, Entry and Validity

Checks
the status of the patient (expired or alive).
Until 2001 all cancer cases were being

coded using International Classication of
Diseases for Oncology (ICDO-2) codes,
2nd Edition, with topography C and
morphology M codes. Data was entered
in CanReg-3 programme, supplied by
the International Agency for Research on
Cancer (IARC), Lyon, France. Canreg-4
software programme and International
Classication of Diseases for Oncology
ICDO-3 began to be used from 2003, since
it was introduced in October 2002. This
programme has a duplicate entry checking
facility, which avoids the same case being
registered more than once. For this report
we used Canreg-4.28. Validity checks are
performed for consistency between items:
site/histology, gender/site and age/site/
histology combinationsby Canreg-4.28.
4. Fourthly, the list of cancer patients

coming for chemotherapy to the tertiary
hospital is obtained.
5. Further, the Diwan of Royal Court sends
abroad certain patients who cannot be
treated in Oman. With the co-operation
of the Diwan of Royal Court, this list of
patients is also obtained since 2002.
6. Some Omani patients living near the
border go to Tuwam Hospital in the United
Arab Emirates (a country bordering Oman)
for diagnosis and management of cancer.
A list of these patients is also obtained
annually.
Details of missing data are sought from all
these above sources so that the registry
can be updated.
3. Completeness of Data Reporting

4.Data Analysis
1. Firstly, data are obtained from all hospitals
with pathology/ hematology laboratories
(Royal, al-Nahdha, Khoula, Salalah and
Sohar Hospitals) by way of copies of
reports of patients diagnosed as cancer to
the registry. Since the middle of 2001, the
Sultan Qaboos University laboratory has
also started sending reports.
Data is rst checked for consistency and

validity using the International Agency for
Research on Cancer (IARC), 1998 software
(Canreg-4.28). Frequency distribution and
incidence tables are generated using the
Canreg-4 programme. Data for individual
cancers are then exported to the EPIINFO
version 6 (Centre for Disease Control and
Prevention, Georgia, Atlanta, USA) for
analysis of incidence by region, gender
and morphological types. The results for
childhood cancers are presented for the
whole Sultanate according to the diagnostic
groups dened in the International
Classication of Childhood Cancers, third
edition, 2005 Steliarova-Foucher et al.,
2005). Bar diagrams and graphs were
made using Microsoft excel.
2. Secondly, since the establishment of

the new National Oncology Center in
November 2004, the chemotherapy and
radiotherapy lists are also obtained once
a week.
3. Thirdly, monthly hospital admission
discharge lists are being sent from the
tertiary hospitals. . From this year, similar
lists are being sent by all the regional
hospitals as well. These lists help in
updating the registry as well as in updating
www.moh.gov.om
14
Registry Methods
Oman National Cancer Registry
5. Denitions
Incidence
is the number of new cancer cases in a
dened population within a specic period.
December) divided by the population at

risk in the same period expressed per
100,000.
Age-specic rate
Incidence rate in a specic age group.
Date of Diagnosis
is the date documented on the histopathology report. For clinical cases, the date of
diagnosis is the date stated in patients
case notes to have cancer.
Multiple primaries
Two or more abnormal growths of tissue
occurring simultaneously. The neoplasms
are histologically different and may be
found in the same or different sites.
Population at Risk
The part of the Omani population that is
susceptible to have a specic cancer.
Metastasis
Metastasis is the distant spread of cancer
from its original site to other organs of the
body, including lymph nodes, skeletal and
or visceral organs.
Crude incidence rate

Is the number of new cancer cases in
the Omani population occurring within a
Gregorian calendar (1st January to 31st
www.moh.gov.om
15
Registry Methods
Table 3 : Age Structure of the World

Standard population of Segi,used for
Age standardization is necessary when Age - adjustment
comparing several populations that difAge Group
Population
fer with respect to age. Hence the World
00-04
12,000
Standard Population of Segi, (Table 3)
05-09
10,000
(Segi M. Cancer mortality for selected sites
10-14
9,000
in 24 countries (1950-57). Sendai: Tohuku
15-19
9,000
University, School of Medicine, 1960) was
20-24
8,000
used to adjust the crude incidence rates
25-29
8,000
and to remove the confounding effect of
30-34
6,000
age. Therefore, the age-adjusted rates
35-39
6,000
(ASR) given in tables 8 and 9 could be
40-44
6,000
used for comparison purposes with other
45-49
6,000
rates where the same world standard pop50-54
5,000
ulation was used, especially those issued
55-59
4,000
by the World Health Organizations agen60-64
4,000
cy, the International Agency for Research
65-69
3,000
on Cancer (IARC), in its periodic publica70-74
2,000
tion Cancer Incidence in Five Continents.
75+
2,000
Age-standardized rate (ASR)
Total
100,000
Table 4 : Stability of data overtime

Incidence Year
Publ. Year
1999
1999
847
2000
866
2001
882
2002
888
2003
889
2004
889
2005
890
2006
891
2007
891
2008
891
2009
891
2010
891
Max
891
Min
847
Average
882
Max-Min
44
Max variation % 5%
2000
2001
2002
2003
2004
2005
2006
2007
2008
883
895
905
905
906
909
910
910
910
910
910
910
883
823.3
27
3.28%
892
892
913
917
920
923
924
931
934
934
934
892
817.1
42
5.10%
783
787
805
821
824
827
831
831
831
831
783
813.6
48
5.89%
841
867
870
872
881
881
881
940
881
841
870.4
40
5.10%
895
911
926
927
939
940
940
940
895
923
45
4.59%
876
906
920
937
937
937
937
876
915.2
61
6.6%
847
848
882
883
883
883
847
865
36
4.16%
837
899
900
900
900
837
878.6
63
7.2%
881
899
901
901
881
891
20
2.20%
2009
2010
915
921
921
876
915
918
6
0.65%
The table shows the total number of registrations annually and the updated numbers for each year following publication.
www.moh.gov.om
16
Trends of cancer
1998 - 2010
www.moh.gov.om
17
Trends of cancer
Table 5: Frequency of Cancers among Omanis, 1998-2010, Males

Site
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
Lip
Tongue
Mouth
10
Salivary glands
Tonsil
Other Oropharynx
Nasopharynx
Hypopharynx
Pharynx unspec.
Oesophagus
10
10
10
11
12
12
11
13
Stomach
50
56
56
56
54
35
34
53
42
35
31
45
27
Small intestine
Colon
15
13
12
12
13
17
22
21
20
17
22
29
Rectum
13
14
17
14
11
17
Anus
Liver
31
35
27
30
13
21
26
34
18
19
30
18
15
Gallbladder etc.
Pancreas
10
13
12
10
11
Nose, sinuses etc.
Larynx
10
10
11
19
Trachea,Bronchus,Lung
32
49
37
44
30
30
31
30
30
41
28
28
Other Thoracic organs
Bone
10
10
12
Melanoma of Skin
Other Skin
22
13
15
18
27
19
19
17
17
22
22
25
21
Mesothelioma
Kaposi sarcoma
Connective,Soft tissue
11
14
13
12
Breast
Penis
Prostate
40
45
37
45
32
30
26
40
27
51
38
43
41
Testis
Other male genital
Kidney
13
15
12
13
15
Renal Pelvis
Ureter
Bladder
23
26
17
19
19
20
19
27
27
28
24
25
32
Other Urinary organs
Eye
Brain, Nervous system
25
15
18
29
17
21
27
17
10
13
14
22
16
Thyroid
14
11
15
10
10
Adrenal gland
Other Endocrine
Hodgkin disease
21
18
18
21
18
19
22
12
20
11
16
12
12
Non-Hodgkin lymphoma
38
43
43
38
37
50
49
43
41
40
40
36
35
Immunoproliferative dis.
Multiple Myeloma
10
12
Lymphoid Leukaemia
19
20
18
20
22
23
28
20
17
10
26
25
16
Myeloid Leukaemia
14
11
14
14
12
22
10
14
20
20
16
11
13
Leukaemia unspec.
12
Other & unspecied
30
24
29
24
27
21
27
19
21
24
19
21
All sites Total
476
477
470
509
444
464
498
499
425
456
429
469
423
All sites but C44
454
464
455
491
417
445
479
482
408
434
407
444
402
www.moh.gov.om
18
Trends of cancer
Table 6: Frequency of Cancers among Omanis, 1998-2010, Females

Site
Lip
Tongue
Mouth
Salivary glands
Tonsil
Other Oropharynx
Nasopharynx
Hypopharynx
Pharynx unspec.
Oesophagus
Stomach
Small intestine
Colon
Rectum
Anus
Liver
Gallbladder etc.
Pancreas
Nose, sinuses etc.
Larynx
Bone
Melanoma of Skin
Other Skin
Mesothelioma
Kaposi sarcoma
Breast
Vulva
Vagina
Cervix Uteri
Corpus Uteri
Uterus unspec.
Ovary
Other Female Genital
Placenta
Kidney
Renal Pelvis
Ureter
Bladder
Eye
Thyroid
Adrenal gland
Other Endocrine
Hodgkin disease
Multiple Myeloma
Lymphoid Leukaemia
Myeloid Leukaemia
Leukaemia unspec.
Other & unspecied
All sites Total
All sites but C44
www.moh.gov.om
1998
1
0
1
2
0
0
1
2
0
13
30
1
13
9
0
13
4
8
2
2
7
0
3
1
12
0
1
4
58
0
2
29
4
6
31
0
0
8
0
0
8
0
4
18
36
2
0
5
19
0
6
13
7
3
34
423
411
1999
0
4
4
2
0
0
4
1
0
12
26
0
3
0
0
16
5
5
0
0
8
1
7
1
24
0
4
5
58
1
0
25
1
6
31
0
0
4
0
0
12
0
5
17
35
1
0
9
19
0
9
9
9
5
25
413
389
2000
0
2
2
1
0
0
2
1
0
9
22
0
11
8
1
13
3
5
1
2
8
0
4
4
20
1
2
10
74
1
3
32
3
0
26
0
5
11
0
0
6
0
2
13
26
3
0
14
29
0
10
11
15
4
19
440
420
2001
0
0
2
2
0
0
0
2
1
7
20
3
10
7
0
11
6
7
1
2
13
0
2
0
14
0
0
4
77
1
1
24
6
6
23
0
2
11
0
1
9
0
1
19
41
3
1
5
27
0
2
14
11
8
17
425
411
2002
0
1
1
0
0
0
5
1
0
5
30
2
9
9
1
8
2
3
4
2
5
0
3
1
7
0
1
7
74
1
2
17
7
3
19
1
0
6
0
0
12
0
2
9
35
1
0
11
23
. 0
1
11
7
11
27
387
380
19
2003
1
2
3
7
0
2
4
2
0
4
19
0
13
11
2
8
2
3
1
1
9
2
5
1
11
0
3
2
63
4
0
34
8
2
17
0
1
10
0
0
8
0
2
8
36
3
0
11
31
. 0
6
12
11
11
21
417
406
2004
2
2
3
4
0
1
2
1
0
4
30
2
12
8
1
6
3
7
0
1
10
0
5
2
10
0
0
10
95
3
2
30
10
3
14
1
1
3
0
0
11
0
2
21
30
1
0
5
33
0
6
12
9
4
22
442
432
2005
0
1
2
1
0
2
0
0
0
5
33
1
15
6
2
9
4
8
2
1
9
1
4
0
17
0
0
6
95
0
1
25
7
1
25
0
0
10
1
1
9
0
3
10
34
0
0
8
26
. 0
5
14
7
2
25
438
421
2006
1
1
1
4
0
0
1
3
0
6
27
1
13
12
2
11
6
4
0
2
13
0
7
1
14
0
0
6
97
3
4
29
8
2
23
2
1
4
0
0
15
0
1
13
38
3
0
5
22
. 0
7
11
9
2
23
458
444
2007
1
2
5
2
0
1
1
1
1
10
18
0
20
12
3
4
4
1
2
1
6
2
2
3
8
0
1
5
105
2
0
23
10
3
23
3
1
6
0
0
8
1
3
11
37
0
0
9
27
0
3
10
10
7
26
444
436
2008
2
2
3
1
0
0
4
1
1
6
15
2
21
9
1
5
6
7
0
0
11
2
3
2
15
0
2
5
106
0
2
28
12
6
20
0
0
16
0
0
9
0
1
13
36
4
0
12
29
0
3
21
14
3
11
472
457
2009
0
2
5
2
0
0
2
0
0
8
23
1
20
11
1
16
5
4
4
3
14
0
1
2
19
0
1
1
105
0
0
11
12
2
13
0
1
8
0
0
9
0
1
11
49
1
0
10
30
0
6
9
13
3
13
452
433
2010
0
3
3
2
0
0
3
0
0
5
23
1
11
15
2
14
1
3
0
1
6
1
3
2
23
0
1
3
115
1
0
35
13
2
15
0
0
9
0
0
8
0
2
14
33
0
0
11
32
0
6
10
14
0
7
453
430
Trends of cancer
Table 7: Age-adjusted Incidence Rates in Omanis, 1998-2010, Males

Site
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
Lip
0.7
0.7
0.5
0.4
0.2
0.8
0.3
0.5
0.1
0.3
Tongue
0.3
1.2
1.3
0.9
0.7
0.9
0.8
1.5
1.3
1.2
0.7
0.3
Mouth
1.6
0.8
0.4
1.5
0.9
1.9
0.3
1.1
1.3
1.7
0.7
Salivary glands
1.3
0.2
0.3
0.5
0.1
1.5
0.1
0.3
0.2
0.2
Tonsil
0.2
0.3
0.3
0.2
0.5
0.6
0.2
0.2
Other Oropharynx
0.5
0.7
0.8
0.8
0.4
0.3
0.2
Nasopharynx
0.8
0.4
1.5
1.3
0.3
0.4
0.7
0.6
0.9
1.3
1.1
0.7
Hypopharynx
0.2
0.4
0.2
0.1
0.7
0.2
1.9
0.3
0.7
Pharynx unspec.
0.3
0.3
0.3
0.2
Oesophagus
2.6
2.6
2.4
2.6
2.8
2.1
3.1
3.5
3.2
2.6
1.3
1.9
2.9
Stomach
13.5
14
12.9
13.2
12
7.8
10.6
16
13
9.7
8.1
11.8
5.4
Small intestine
0.2
0.3
0.2
0.4
0.6
0.4
0.5
0.5
0.3
Colon
3.5
1.5
2.4
2.7
2.9
4.3
5.5
5.2
3.9
4.8
5.2
Rectum
2.5
1.8
1.1
1.6
3.1
1.6
4.5
3.7
2.2
4.2
1.7
Anus
0.2
0.9
0.3
1.2
0.8
0.7
0.6
0.3
0.3
0.5
0.5
0.2
Liver
7.8
9.5
6.1
6.8
9.8
4.5
4.5
4.5
3.1
Gallbladder etc.
0.5
0.8
1.2
0.5
0.7
0.7
1.1
2.3
0.5
1.8
0.9
0.7
1.1
Pancreas
1.3
1.7
2.3
0.5
1.4
4.1
2.3
1.9
1.2
2.3
2.3
2.4
Nose, sinuses etc.
0.2
0.7
0.5
0.1
0.8
0.6
0.5
0.9
0.1
0.2
0.2
Larynx
2.7
1.3
1.2
0.4
0.4
1.7
2.6
2.6
2.5
1.3
1.1
0.8
2.3
Trachea,Bronchus,Lung 8.4
12.9
8.8
10
6.8
6.9
9.6
8.3
8.2
11.6
7.5
7.3
4.2
0.2
0.2
0.6
0.5
0.2
0.1
0.4
0.1
0.6
0.3
0.1
0.7
Bone
1.1
0.8
0.7
0.2
0.7
0.9
1.3
0.9
0.3
0.5
0.3
0.7
1.3
Melanoma of Skin
0.3
0.2
0.4
0.3
1.1
0.3
0.3
0.5
0.5
0.3
Other Skin
5.8
3.1
3.4
5.4
4.1
5.3
5.4
5.1
5.9
5.4
6.2
4.4
Mesothelioma
0.4
0.4
0.2
0.2
0.3
0.3
0.3
0.3
1.3
0.2
0.5
1.2
0.7
0.5
0.7
0.5
0.5
0.5
0.3
Kaposi sarcoma
1.6
1.3
0.9
1.3
1.7
0.8
0.6
0.4
1.4
0.7
1.8
Breast
0.6
0.7
0.7
1.4
0.8
1.1
0.7
1.7
1.8
0.9
0.1
1.4
1.5
0.2
0.3
0.2
Prostate
Penis
11.1
12
10.6
7.4
6.9
8.5
12.3
8.2
15.2
11.4
12
8.5
Testis
0.5
0.5
0.2
0.7
0.9
0.6
0.5
0.7
0.4
0.7
0.4
0.3
0.2
0.1
0.1
1.3
1.6
2.5
1.2
1.1
2.6
1.7
2.2
1.2
1.1
1.5
3.2
2.7
0.7
Other male genital

Kidney
Renal Pelvis
Ureter
0.3
0.3
Bladder
5.8
6.6
3.8
4.4
4.1
4.8
5.2
7.3
7.5
7.6
6.7
6.7
6.7
0.2
0.3
0.1
0.2
0.6
Eye
0.8
0.6
0.3
0.3
0.8
0.9
0.5
1.1
0.2
0.1
3.6
2.8
4.4
3.2
3.2
4.1
2.8
1.5
2.3
1.8
3.1
Thyroid
1.3
1.7
1.1
2.8
1.6
3.2
1.6
0.8
1.4
1.6
1.5
0.4
0.1
0.2
0.1
0.3
0.2
0.2
0.4
0.1
0.3
0.5
Adrenal gland
Other Endocrine
0.1
0.2
0.3
0.1
0.1
0.1
Hodgkin disease
3.6
2.2
2.7
2.4
2.5
2.8
2.2
1.6
2.8
1.4
1.5
Immunoproliferative dis. 0.2

Multiple Myeloma
7.9
7.3
7.1
9.7
10.6
7.8
6.9
8.9
6.5
0.3
1.6
2.4
2.1
1.4
0.8
3.1
3.5
1.2
2.6
2.2
1.9
1.3
Lymphoid Leukaemia
1.9
2.6
2.5
2.6
2.4
3.3
3.5
2.2
2.5
1.3
2.5
1.7
Myeloid Leukaemia
2.8
2.2
2.9
1.8
1.9
3.1
1.9
2.6
3.5
3.8
3.2
1.5
1.7
Leukaemia unspec.
0.6
0.6
0.6
1.2
1.2
1.1
0.6
0.4
0.1
0.4
0.2
0.3
0.8
Other & unspecied
7.8
5.2
6.8
5.3
4.2
7.6
4.6
5.8
5.6
4.8
1.7
All sites Total
110.9
109.1
99.2
104.3
85.4
92.3
120.4 124.2
101.3 108.5
98.4
101.3
76.8
All sites but C44
105.1
106
95.8
100.3
80
88.2
115.1 118.7
96.2
93
95.1
72.4
www.moh.gov.om
20
102.6
Trends of cancer
Table 8: Age-adjusted Incidence Rates in Omanis, 1998-2010, Females

Site
1998
Lip
0.4
Tongue
0
Mouth
0.2
Salivary glands
0.5
Tonsil
0
Other Oropharynx
0
Nasopharynx
0.2
Hypopharynx
0.4
Pharynx unspec.
0
Oesophagus
4.4
Stomach
8.2
Small intestine
0.3
Colon
3.1
Rectum
2.1
Anus
0
Liver
3.3
Gallbladder etc.
1.1
Pancreas
2.4
Nose, sinuses etc.
0.5
Larynx
0.4
Trachea,Bronchus,Lung 1.6
0
Bone
0.2
Melanoma of Skin
0.2
Other Skin
3.1
Mesothelioma
0
Kaposi sarcoma
0.2
Connective,Soft tissue 0.3
Breast
13.4
Vulva
0
Vagina
0.6
Cervix Uteri
7.2
Corpus Uteri
0.9
Uterus unspec.
1.3
Ovary
7.8
0
Placenta
0
Kidney
1.7
Renal Pelvis
0
Ureter
0
Bladder
1.6
0
Eye
0.8
3
Thyroid
6.8
Adrenal gland
0.3
Other Endocrine
0
Hodgkin disease
0.5
Non-Hodgkin lymphoma 3.8
Immunoproliferative dis. 0
Multiple Myeloma
1.9
Lymphoid Leukaemia
2.1
Myeloid Leukaemia
1
Leukaemia unspec.
0.6
Other & unspecied
8.9
All sites Total
97.6
All sites but C44
94.5
www.moh.gov.om
1999
0
0.9
1
0.4
0
0
0.8
0.4
0
3.3
7
0
1
0
0
4.1
1.4
1.2
0
0
2.1
0.1
0.6
0.1
5.5
0
0.9
1.1
13.8
0.4
0
6.3
0.2
1.8
7
0
0
1
0
0
3.4
0
0.9
2.4
5.9
0.2
0
2
3.3
0
2.5
1
1.9
0.4
6.6
92.7
87.2
2000
0
0.5
0.4
0.2
0
0
0.2
0.2
0
2.1
5.6
0
2.4
2
0.2
3.1
0.8
1.2
0.3
0.4
2
0
0.4
0.9
4.8
0.2
0.4
1.5
15.6
0.3
0.6
7.3
0.8
0
5.8
0
0.8
1.8
0
0
1.5
0
0.2
1.9
4.2
0.5
0
1.9
5.4
0
2.7
1.3
2.5
0.7
4.5
90.3
85.5
2001
0
0
0.4
0.3
0
0
0
0.4
0.3
1.7
4.4
0.7
2.4
1.5
0
2.5
1.4
1.8
0.1
0.5
3.2
0
0.4
0
3.3
0
0
0.7
16
0.3
0.2
5.7
1.5
1.4
4.5
0
0.3
2
0
0.2
2.1
0
0.2
3.2
7
0.3
0.1
0.7
5.1
0
0.5
1.7
1.8
1.2
3.6
85.9
82.6
2002
0
0.1
0.1
0
0
0
0.6
0.2
0
1.1
6.8
0.5
2.1
2.2
0.1
1.7
0.3
0.7
0.8
0.4
1
0
0.2
0.1
1.5
0
0.2
1
14.8
0.2
0.5
3.8
1.8
0.7
3.7
0.2
0
0.7
0
0
2.8
0
0.3
1.1
6.1
0.1
0
1.3
4.5
0
0.2
1.3
0.9
1.6
5.5
73.6
72.1
21
2003
0.2
0.4
0.7
1.2
0
0.6
0.7
0.5
0
0.9
4
0
2.4
2.6
0.5
1.9
0.5
0.8
0.3
0.3
2.2
0.3
0.3
0.2
2.5
0
0.6
0.3
13.6
0.8
0
7.6
1.7
0.6
3.6
0
0.1
2.2
0
0
2
0
0.2
1.2
5.9
0.3
0
1.6
5.2
0
1.5
1.7
2.1
1.8
4.4
82.7
80.3
2004
0.2
0.3
0.6
0.8
0
0.3
0.1
0.5
0
1.5
9.7
0.6
3.4
1.9
0.4
1.9
1.2
2.7
0
0.2
3.1
0
0.8
0.5
3.7
0
0
1.4
22.9
1
0.4
7.6
3.1
0.6
3.1
0.1
0.1
0.6
0
0
3.6
0
0.2
2.5
4.8
0.1
0
0.6
8.7
0
1.9
2
1.8
0.7
6.2
108.8
105.1
2005
0
0.2
0.6
0.4
0
0.7
0
0
0
1.9
10.1
0.4
3.4
1.2
0.7
2.2
1.1
2
0.4
0.2
2.4
0.1
0.7
0
4
0
0
0.7
21.8
0
0.1
7.4
2.2
0.4
5.3
0
0
1.8
0.3
0.3
2.9
0
0.5
1.4
6.4
0
0
1.7
6
0
1.5
1.8
1.3
0.1
6.5
103.3
99.3
2006
0.3
0.4
0.3
0.7
0
0
0.2
0.7
0
2
6.8
0.3
3
2.7
0.5
2.4
1.8
1
0
0.8
3.6
0
0.8
0.1
4.1
0
0
0.8
22.6
1
1.5
6.4
2.2
0.5
4.9
0.5
0.2
0.8
0
0
4.8
0
0.3
2.2
6.3
0.3
0
0.7
4.5
0
2.3
1.9
1.3
0.2
6.6
105.3
101.2
2007
0.4
0.5
1.3
0.4
0
0.3
0.2
0.3
0.1
3.1
5.1
0
4.7
2.6
0.6
1.2
1.3
0.3
0.3
0.3
1.6
0.4
0.1
0.5
2.1
0
0.2
0.7
22.1
0.3
0
5.7
2.8
0.8
5.5
0.8
0.1
1.2
0
0
2.1
0.2
0.4
1.7
5.6
0
0
1.5
6
0
0.8
1
1.5
1.2
6.9
97.1
95.1
2008
0.5
0.3
0.8
0.1
0
0
1
0.3
0.3
1.7
4.1
0.6
4.3
1.9
0.3
1.7
1.5
1.6
0
0
3
0.5
0.4
0.5
4.7
0
0.7
0.7
22
0
0.8
6.6
2.9
1.6
3.4
0
0
3.7
0
0
2.5
0
0.2
1.7
4.6
0.4
0
1.8
5.5
0
0.9
2.4
2.1
0.5
2.6
97.8
93.1
2009
0
0.3
1.5
0.3
0
0
0.4
00
00
2.4
5.8
0.3
4.2
2.4
0.3
3.8
1.1
1
1.1
0.8
3.4
0
0.1
0.4
4.8
0
0.4
0.1
19.9
0
0
2.3
3.2
0.4
2.4
0
0.2
1.7
0
0
1.8
0
0.3
1.3
6.4
0.1
0
1.8
5.7
0
1.6
1
2.1
0.5
2.6
90.2
85.3
2010
0
0.3
0.2
0.1
0
0
0.2
0
0
0.5
2.3
0.1
0.9
1.5
0.2
1.5
0.1
0.3
0.0
0.1
0.7
0.0
0.2
0.2
2.2
0
0.1
0.1
9.7
0.1
0.0
3.4
1.3
0.2
1.2
0
0.0
0.7
0
0
0.7
0
0.2
1.0
2.2
0.0
0
0.6
3
0
0.7
0.5
1
0.0
0.6
38.9
36.7
Overall Results
Overall Results
Table 9. : Distribution of Cancer Cases in Oman by Nationality
Nationality
Frequency
Percentage (%)
Omanis
876
92.31
Non-Omanis
73
7.69
Total
949
100
The male : female ratio was 0.93 :1. 60 cases (6.8%) were reported in children aged 14 years and
below. The median age at diagnosis was 53 years. This was higher in males (median age 57
years) than in females (median age 50 years).
Table 10 : Distribution of Cancer Cases Among Omanis by Gender

Gender
Frequency
Percentage (%)
Male
423
48.29
Female
453
51.71
Total
876
100
www.moh.gov.om
22
Overall Results
Incidence rate (per 100,000)
800
700
600
500
400
300
200
100
0
10-19
20-29
30-39
40-49
Figure 2: Age - Specic incidence rates by gender, 2010
0-9
Age group (years)
50-59
60-69
23
www.moh.gov.om
Overall Results
Table 11: Frequency of Incident Cases in Omani Males , 2010

SITE
ALL
AGE 0
-5 -10 -15
-20
-25 -30
-35 -40
-45 -50
-55
-60 -65
-70 75+
% of
ICD
AGES
UNK. -4
-9 -14 -19
-24
-29 -34
-39 -44
-49 -54
-59
-64 -69
-74
Total
(10th)
Lip
0.20%
C00
Tongue
0.50%
C01-C02
Mouth
0.70%
C03-C06
Salivary glands
0.20%
C07-C08
Tonsil
0.20%
C09
Other Oropharynx
0.20%
C10
Nasopharynx
0.90%
C11
Hypopharynx
0.00%
C12-C13
Pharynx unspec.
0.00%
C14
Oesophagus
13
3.10%
C15
Stomach
27
6.40%
C16
Small intestine
0.20%
C17
Colon
29
6.90%
C18
Rectum
2.10%
C19-C20
Anus
0.00%
C21
Liver
15
3.50%
C22
C23-C24
Gallbladder etc.
1.20%
Pancreas
11
2.60%
C25
Nose, sinuses etc.
0.20%
C30-C31
Larynx
11
2.60%
C32
Trachea,Bronchus,Lung 19
4.50%
C33-C34
0.00%
C37-C38
Bone
12
2.80%
C40-C41
Melanoma of Skin
0.50%
C43
Other Skin
21
5.00%
C44
C45
Mesothelioma
0.00%
Kaposi sarcoma
0.50%
C46
12
2.80%
C47;C49
Breast
1.70%
C50
Penis
0.20%
C60
Prostate
41
12
9.70%
C61
Testis
0.90%
C62
Other male genital
0.00%
C63
Kidney
15
3.50%
C64
Renal Pelvis
0.00%
C65
Ureter
0.00%
C66
Bladder
32
7.60%
C67
0.00%
C68
Eye
0.00%
C69
16
3.80%
C70-C72
Thyroid
0.50%
C73
Adrenal gland
0.90%
C74
Other Endocrine
0.00%
C75
Hodgkin disease
12
2.80%
C81
Non-Hodgkin lymphoma 35
8.30%
C82-C85;C96
0.00%
C88
Multiple Myeloma
1.90%
C90
Lymphoid Leukaemia
16
3.80%
C91
Myeloid Leukaemia
13
3.10%
C92-C94
Leukaemia unspec.
1.40%
C95
Other & unspecied
1.90%
Other
All sites Total
423
18 10
10
17
14 10
18
21
31
34
43
54
44
49
42 100.00%
All
All sites but C44
402
18 10
10
17
14 10
18
20
30
34
38
50
43
43
39 95.00%
Not C44
www.moh.gov.om
24
Overall Results
Table 12: Frequency of Incident Cases in Omani Females, 2010

SITE
-5
-10
-15
-20
-25
-30 -35 -40 -45
-50
-55
-60
-65 -70 75+
% of
ICD
AGES UNK. -4
ALL
AGE
-9
-14
-19
-24
-29
-34 -39 -44 -49
-54
-59
-64
-69 -74
Total
(10th)
Lip
0.00%
C00
Tongue
0.70%
C01-C02
Mouth
0.70%
C03-C06
Salivary glands
0.40%
C07-C08
Tonsil
0.00%
C09
Other Oropharynx
0.00%
C10
Nasopharynx
0.70%
C11
Hypopharynx
0.00%
C12-C13
Pharynx unspec.
0.00%
C14
Oesophagus
1.10%
C15
Stomach
23
5.10%
C16
Small intestine
0.20%
C17
Colon
11
2.40%
C18
Rectum
15
3.30%
C19-C20
Anus
0.40%
C21
Liver
14
3.10%
C22
C23-C24
Gallbladder etc.
0.20%
Pancreas
0.70%
C25
Nose, sinuses etc.
0.00%
C30-C31
Larynx
0.20%
C32
1.30%
C33-C34
0.20%
C37-C38
Bone
0.70%
C40-C41
Melanoma of Skin
0.40%
C43
Other Skin
23
5.10%
C44
C45
Mesothelioma
0.00%
Kaposi sarcoma
0.20%
C46
0.70%
C47;C49
Breast
115
15
10
09
18
21
25.40%
C50
Vulva
0.20%
C51
Vagina
0.00%
C52
Cervix Uteri
35
7.70%
C53
Corpus Uteri
13
2.90%
C54
Uterus unspec.
0.40%
C55
Ovary
15
3.30%
C56
0.00%
C57
Placenta
0.00%
C58
Kidney
2.00%
C64
C65
Renal Pelvis
0.00%
Ureter
0.00%
C66
Bladder
1.80%
C67
0.00%
C68
Eye
0.40%
C69
14
3.10%
C70-C72
Thyroid
33
10
7.30%
C73
Adrenal gland
0.00%
C74
Other Endocrine
0.00%
C75
Hodgkin disease
11
2.40%
C81
7.10% C82-C85;C96
0.00%
C88
Multiple Myeloma
1.30%
C90
Lymphoid Leukaemia
10
2.20%
C91
Myeloid Leukaemia
14
3.10%
C92-C94
Leukaemia unspec.
0.00%
C95
Other & unspecied
1.50%
Other
All sites Total
453
12
11
29
40
27
39
37
51
49
44
32
30 32 100.00%
All sites but C44
430
12
11
28
40
25
38
37
49
46
42
27
30 27 94.90% Not C44
www.moh.gov.om
25
All
Overall Results
Table 13: Age-specifc Incidence Rates among Omani Males, 2010

SITE
0 -5 -10 -15 -20
-25 -30 -35 -40 -45
-50 -55
-60 -65
-70 75+ CRUDE ASR
AGES UNK. -4 -9 -14 -19 -24
ALL
AGE
-29 -34 -39 -44 -49
-54 -59
-64 -69
-74
ICD
RATE World (10th)
Lip
8.7
0.1
0.3
C00
Tongue
3.5
0.2
0.3
C01-C02
Mouth
3.5
5.9
6.2
0.3
0.7
C03-C06
Salivary glands
3.5
0.1
0.2
C07-C08
Tonsil
3.5
0.1
0.2
C09
Other Oropharynx
5.9
0.1
0.2
C10
Nasopharynx
0.8
2.8
4.1
8.7
0.4
0.7
C11
Hypopharynx
0.0 C12-C13
Pharynx unspec.
0.0
Oesophagus
13
31
26
33.1
1.3
2.9
C15
Stomach
27
31 34.7 27.1 33.1
2.8
5.4
C16
Small intestine
8.7
0.1
0.3
C17
Colon
29
0 0.9
1.6
1.3
52
16.6
5.2
C18
Rectum
6.2
8.3
0.9
Anus
0.0
C21
Liver
15
1.5 0
2.8
8.2 23.6 18.6 8.7
8.3
1.5
3.1
C22
Gallbladder etc.
4.1 11.8
6.2
0.5
Pancreas
11
8.2 5.9
12.4 17.3
Nose, sinuses etc.
5.9 5.5 3.5 16.5 5.9

0
5.9 2.8 13.9 16.5 17.7

2.8 6.9
5.5 3.5
0
3.5
0
Larynx
11
5.5
19
2.8 6.9
4.1 5.9
0
12.4 17.7
0
23.6
C14
1.7 C19-C20
1.1 C23-C24
1.1
0.1
6.2
18.1
1.1
2.3
1.9
4.2 C33-C34
31 17.3 27.1 16.6
2.4
0.2
0.0
C25
C30-C31
C32
Bone
12
2.8
2.4
2.5
6.2
8.7
1.2
8.3
0.2
0.3
C43
2.1
4.4
C44
C37-C38
1.3 C40-C41
Melanoma of Skin
Other Skin
21
Mesothelioma
0.0
0.0
C45
Kaposi sarcoma
0.8
5.9
0.2
0.3
C46
12
0.9
0.8
0.8
4.1
8.3
1.2
Breast
5.9
12.4
8.3
0.7
1.5
C50
Penis
6.2
0.1
0.2
C60
Prostate
41
4.2
8.5
C61
Testis
0.8 0
0.8
1.3
0.4
0.3
C62
Other male genital
0.0
0.0
C63
Kidney
15
1.5 0
1.3
8.2
6.2
26
16.6
1.5
2.7
C64
Renal Pelvis
C65
Ureter
C66
Bladder
32
3.3
6.7
C67
C68
Eye
0.0
0.0
C69
16
3 0.9 0.9
0.8
0.8
3.9
6.9
6.2
8.3
1.6
Thyroid
Adrenal gland
Other Endocrine
0.8 0
2.8 3.5
2.8 3.5
2.8 6.9
29.5 24.8 8.7 54.2 24.8
4.1 17.7 43.4 69.4 108.3 74.5
2.8 6.9 20.6 11.8 37.2 34.7 63.2 33.1
1.8 C47- C49
2.0 C70-C72
3.5
5.9
0.2
0.4
1.5 0
4.1
0.4
0.5
C74
0.0
0.0
C75
8.7
C81
Hodgkin disease
12
0.9
1.6
1.6
1.3
5.9
35
0 3.7
1.6
Multiple Myeloma
2.8 3.5
Lymphoid Leukaemia
16
2.3 2.8 0.9
0.6
1.6
1.3
2.8
Myeloid Leukaemia
13
1.5 0.9
2.7
Leukaemia unspec.
0.9
0.8
0.8
Other & unspecied
2.8
All sites Total
423
14 9
14
14
13
35
58 107 140 254
All sites but C44
402
14 9
14
14
13
35
55 104 140 224
www.moh.gov.om
6.2 17.3
0.8 0
0
0
3.9 2.8 3.5
26
4.1 5.9
5.5 17.3 12.4 29.5

0
4.1 5.9
0
6.2
2.6 36.1 8.3
C73
1.2
1.5
3.6
6.0 C82-C85
0.0
0.0
C88
16.6
0.8
1.3
C90
C91
6.2
1.6
1.7
4.1
16.6
1.3
1.7 C92-C94
6.2
8.3
0.6
0.8
C95
11.8 18.6
0.8
1.7
Other
335 382 442 348
43.3
76.8
All
310 373 388 323
41.1
72.4 Not C44
Overall Results
Table 14: Age-specifc Incidence Rates among Omani Females, 2010

SITE
0 -5 -10 -15 -20
-25 -30 -35 -40 -45
-50 -55
-60 -65
-70 75+ CRUDE ASR
AGES UNK. -4 -9 -14 -19 -24
ALL
AGE
-29 -34 -39 -44 -49
-54 -59
-64 -69
-74
RATE World
ICD
(10th)
Lip
C00
Tongue
0.7
1.9
4.5
0.2
0.3
C01-C02
Mouth
1.4
8.1
0.2
0.2
C03-C06
Salivary glands
0.5
1.4
0.1
0.1
C07-C08
Tonsil
C09
Other Oropharynx
C10
Nasopharynx
0.7
0.2
0.2
C11
Hypopharynx
C12-C13
Pharynx unspec.
Oesophagus
Stomach
23
0.4
Small intestine
1.7
Colon
11
0.7
2.8
Rectum
15
0.7
4.2
Anus
Liver
14
Gallbladder etc.
Pancreas
Nose, sinuses etc.
Larynx
0.1
0.1
C32
2.8
9.4
4.4
0.3
0.7
C33-C34
0.4 0
0.1
0.0
C37-C38
Bone
0 0.5 0.5
1.4
0.2
0.2
C40-C41
Melanoma of Skin
0.5
4.5
0.1
0.2
C43
Other Skin
23
0.8
0.5
1.4
1.2
2.2
C44
Mesothelioma
C45
Kaposi sarcoma
3.1
0.1
0.1
C46
0.5
0.2
0.1
C47;C49
Breast
115
4.4
9.9
9.7
C50
Vulva
2.8
0.1
0.1
C51
Vagina
0.0
0.0
C52
Cervix Uteri
35
1.3
8.1
1.8
3.4
C53
Corpus Uteri
13
1.3
1.7
Uterus unspec.
1.9
Ovary
15
0.8
1.5
1.3
Placenta
Kidney
0.4 0
0.8
0.5
Renal Pelvis
Ureter
Bladder
0.5
0.7
Eye
0.4 0
14
1.2 0
0.5
0.5
1.3
Thyroid
33
0.8
1.5
6.6
Adrenal gland
Other Endocrine
Hodgkin disease
11
0 0.5 0.9
0.4
0.8
0.7
1.7
Multiple Myeloma
Lymphoid Leukaemia
10
1.2 0.9 1.4
0.4
Myeloid Leukaemia
14
0.4 0
0.4
0.4
0.7
2.8
1.9
0.8 0
2.8 1.7
1.4 6.8
C14
3.9 5.6
3.1
0.3
0.5
C15
3.9 8.4
12.5 8.9 19.5 12.1
1.2
2.3
C16
0.1
0.1
C17
1.9 2.8
3.1
4.5
4.9
0.6
0.9
C18
1.9 16.8
6.2
9.7
0.8
1.5
C19-C20
4.9
0.1
0.2
C21
9.4
9.7
0.7
1.5
C22
4.9
0.1
0.1
C23-C24
5.6
4.9
0.2
0.3
C25
0.0
0.0
C30-C31
1.9 5.6
3.9 3.4
6.2 22.3 24.3 20.2
10 12.5 30.7 40.8 25.2 18.7 22.3 24.3 32.2
Leukaemia unspec.
Other & unspecied
6.9 3.4
7.8 22.4 12.5 17.8

6.2
8.9
9.7
0.7
1.3
C54
4.9
0.1
0.2
C55
8.4
6.2
4.5
4.9
0.8
1.2
C56
C57
0.0
0.0
C58
3.4
1.9
3.1
4.9
0.5
0.7
C64
C65
C66
2.8
3.1
4.9
0.4
0.7
C67
C68
3.1
0.1
0.2
C69
1.4 1.7
3.9
3.1
4.5
0.7
1.0
C70-C72
6.9 1.7
7.8
3.1
8.9
4.9
1.7
2.2
C73
0.0
0.0
C74
C75
3.4
0.6
0.6
C81
1.7
C82-C85;C96
1.4 1.7
4.2 3.4
1.4 1.7
1.9 8.4
5.8 8.4
0
18.7 13.4 9.7 16.1

0
C88
6.2
4.5
0.3
0.7
C90
4.9
0.5
0.5
C91
8.9
0.7
C92-C94
3.9 2.8
4.9 8.1
0.0
0.0
C95
1.9
9.7
0.4
0.6
Other
All sites Total
453
14
27
27 54
63
99 137 137 143 146 129
23.4
38.9
All
All sites but C44
430
14
27
25 53
63
95 129 131 120 146 109
22.3
36.7
Not C44
www.moh.gov.om
27
Overall Results
Table 15: Incident Cases by most valid basis of diagnosis among Omanis, 2010
Site
A*
B*
C*
D*
Total
Lip
Tongue
Mouth
Salivary Glands
Oropharynx
Nasopharynx
Hypopharynx
Oesophagus
18
18
Stomach
49
50
Colon
39
40
Small intestine
Rectum
24
24
29
Liver
29
Gall Bladder
Pancreas
14
14
Nose, Sinuses
1
12
Larynx
12
Trachea, Bronchus, Lung
24
25
Bone
15
15
Connective tissue
15
15
Melanoma
Skin
43
44
Kaposis sarcoma
Breast
121
122
35
Cervix uteri
35
Uterus Unspecied
15
15
Ovary
13
15
Other female genital
0
41
Prostate
41
Testis
Kidney
24
24
Bladder
40
40
Eye
Brain, Nervous System
27
29
Thyroid
35
35
Hodgkins Disease
23
23
Non Hodgkins Disease
67
67
Plasmacytoma
14
14
Leukemia
59
59
Other and Unspecied
25
25
Total
867
876
Percentage of total
0.80
98.97
0.23
100
*Key to basis of diagnosis

A = Death certicate only
B = Non-microscopic: clinical, clinical investigation, and specic tumour markers, exploratory surgery
without histology
C = Microscopic: cytology, histology of primary, and histology of metastasis
D = Unknown
www.moh.gov.om
28
Overall Results
Common Cancers in Omanis

Table 16: Ten Most Common Cancers among Omanis (Males & Females)
Topography
Frequency
Breast
122*
Non-Hodgkin Lymphoma
67
Leukemia
59
Stomach
50
Other skin
44
Prostate
41
Bladder
40
Colon
40
Thyroid
35
Brain
30
* includes 7 cases of male breast cancer
Figure 3: Most Common Cancers in Oman
3.8%
Brain
Thyroid
4.5%
7.3%
Lung/Bronchus
Breast
Stomach
6.4%
6.9%
5.1%
Colon
3.6%
7.6%
Kidney
Bladder
Ovary
Uterus
Cervix
Rectum
3.3%
3.3%
7.7%
3.3%
Prostate
9.7%
5.0%
www.moh.gov.om
25.4%
Skin, others
8.3%
Non-Hodgkin
Lymphoma
8.3%
Leukemia
5.1%
7.1%
5.3%
29
www.moh.gov.om
Breast
122
30
59
50
44
41
Non-Hodgkin Leukemia Stomach Other skin Prostate

Lymphoma
67
Bladder
40
Colon
40
Thyroid
35
Brain
30
Figure 4 : Frequency distribution of the ten most common cancers among Omanis
(males and females), 2010
Overall Results
(Frequency)
Overall Results in Oman and GCC Comparison
Overall Results
Table 17: Ten Most Common Cancer among Omani Males and Females 2010
Female
Male
Frequency
Percentage (%)
Breast
115
25.4
8.3
Cervix Uteri
35
7.7
35
8.3
Thyroid
33
7.3
32
7.6
Non Hodgkin Lymphoma
32
7.1
Colon
29
6.9
Leukemia
24
5.3
Stomach
27
6.4
Other skin
23
5.1
Topography
Frequency
Percentage (%)
Prostate
41
9.7
35
Leukemia
Bladder
Topography
Other Skin
21
5.0
Stomach
23
5.1
19
4.5
Rectum
15
3.3
Brain
16
3.8
Ovary
15
3.3
Kidney
15
3.6
Uterus
15
3.3
Table 18: Five Most Common Cancer among nationals of GCC States (1998-2007)
Male
Oman
UAE
Bahrain
KSA
Qatar
Kuwait
Stomach
Lung
Lung
Non-Hodgkin
Lymphoma
Lung
Colorectal
Non-Hodgkin
Lymphoma
Colorectal
Colorectal
Colorectal
Colorectal
Non-Hodgkin
Lymphoma
Leukemia
Non-Hodgkin Prostate
Lymphoma
Liver
Liver
Lung
Prostate
Prostate
Bladder
Leukemia
Leukemia
Leukemia
Lung
Leukemia
Leukemia
Lung
Bladder
Prostate
Breast
Breast
Breast
Breast
Breast
Breast
Thyroid
Leukemia
Colorectal
Lung
Leukemia
Colorectal
Thyroid
Thyroid
Colorectal
Non-Hodgkin
Lymphoma
Thyroid
Colorectal
Non-Hodgkin
Lymphoma
Colorectal
Thyroid
Non-Hodgkin
Lymphoma
Stomach
Cervix Uteri
Ovary
Leukemia
Corpus uteri
Leukemia
Thyroid
Female Cervix Uteri
www.moh.gov.om
31
Overall Results
Figure 5 : The most frequent types of cancer by gender

(0-14 years)
Lymphoid Leukemias
19.4
33.3
11.1
Neuroplastoma
Lymphoid Leukemias
12.5
Hodgkin Lymphoma
12.5
Neuroplastoma
Acute myeloid Leukemias
8.3
5.6
8.3
Ewing Sarcoma
Medulloblastoma
5.6
4.2
Acute myeloid Leukemias
Other
50
remaining
sites
60
50
29.2
40
30
20
10
10
20
30
Other remaining sites
40
50
60

(15-34 years)
21.6
Leukemia
27.3
13.7
Bone
17
11.8
Breast
Thyroid
7.9
Ovary
Hodgkin Lymphoma
9.8
6.8
Colon
9.8
6.8
Leukemia
Other remaining 33.3

sites
60
50
www.moh.gov.om
34.2
40
30
20
10
10
32
20
30
Other remaining sites
40
50
60
Overall Results

(35-54 years)
Colon
11.5
37.7
10.6

Bladder
7.7
Stomach
7.7
70
9.1
Thyroid
8.4
Cervix uteri
5.2
5.8
Leukemia
Other
remaining 56.7
sites
Breast
3.9
Stomach
Other
39.6 remaining
sites
60
50
50
40
30
20
10
10
20
30
40
50
60

(55+ years)
16.8
Prostate
17.6
9.6
8.2
9.6
Cervix uteri
7.3
8.6
Stomach
9.9
Bladder
Other skin
Stomach
Breast
Other skin
Other
remaining 51.8
sites
60
50
www.moh.gov.om
Other
remaining
sites
46.6
40
30
20
10
33
10
20
30
40
50
60
Overall Results
Regional Distribution
The high frequency of cancer reported from Muscat could be biased since majority of the cancer cases are
referred to the Royal hospital, Muscat and people sometimes give a local address in Muscat, rather than
giving their original place of residence.
Figure 9 : Regional Distribution of Incident cases, 2010

(Incidence rates are per 100,000 population)
Musandam
(Sultanate of Oman)
23.1
(5)
Madha
(Sultanate of Oman)
37.5
(143)
37.6
(87)
Adh
Dhahirah
Muscat
56.0
(225)
46.3
(74)
Ad
Dakhliyah
40.6
(108)
Al Wusta
47.8
(9)
Dhofar
60.5
(98)

Data of Buraimi Governorate included in Adh Dhahirah region
The number in the brackets is frequency.
Unknown (22)
www.moh.gov.om
34
33.5
(45)
38.6
(60)
Cancers by Site
www.moh.gov.om
35
Lymphoma
Lymphoma
Table 19: Gender Distribution of Lymphomas
Gender
Hodgkins Lymphoma
Frequency
Crude
incidence
Male
Female
Total
12
11
23
1.2
0.6
ASR
1.5
0.6
Frequency
Crude
incidence
ASR
35
3.6
32
1.7
67
Note : Incidence per 100,000 per year
Figure 10: Age-standardized incidence rates of Hodgkin lymphoma in Oman and

some selected countries
2010
5
Figure 11: Age-standardized incidence rates of Non-Hodgkin lymphoma in Oman

and some selected countries
2010
5
Note:
Data of GCC countries are from 1998-2005; data of Algeria, UK, USA and Japan are from 1993-1997; For USA-white
population data was used.
www.moh.gov.om
36
Lymphoma
Figure 12: Morphology of Hodgkin Disease

Unspecied
Hodgkin's disease
26%
Nodular sclerosis
35%
Lymphocytic
predominace
13%
Lymphocytic
depletion
4%
Mixed cellularity
22%
Figure 13: Morphology of Non-Hodgkin lymphoma

Angioimmunoblastic Tcell lymphoma
3%
Marginal zone b-cell

lymphoma,NOS*
1%
Precursor cell
lymphoblastic
lymphoma,NOS*
4%
Anaplastic large cell

lymphoma
4%
Malignant
lymphoma, NOS*
4%
Mantle cell lymphoma

3%
Non- Hodgkins
lymphoma, NOS*
37%
Cutaneous T-cell
lymphoma,NOS*
1%
Follicular lymphoma
6%
Burkitts
lymphoma, NOS*
7%
Mature T-cell
lymphoma, NOS*
1%
Malignant
lymphoma, lymphoplasm
acytic
1%
www.moh.gov.om
Malignant
lymphoma, large
B-cell, diffuse, NOS*
28%
37
Hodgkin Lymphoma
Figure 14 : Incidence of Hodgkins Lymphoma by Region

Musandam
(Sultanate of Oman)
0.0
(0 )
Madha
(Sultanate of Oman)
0.8
(3)
Muscat
0.4
(1)
1.5
(6)
Adh
Dhahirah
0.6
(1)
Ad
Dakhliyah
3.0
(8)
Al Wusta
0.0
(0)
Dhofar
1.2
(2)
Source: Ministry of National Economy

Note : The map is not the authority on international boundaries
The number in the brackets is frequency
Unknown (1)
www.moh.gov.om
38
0.0
(0)
0.6
(1)
Figure 15 : Incidence of Non-Hodgkin Lymphoma by Region

Musandam
(Sultanate of Oman)
0.0
(0)
Madha
(Sultanate of Oman)
3.1
(12)
Muscat
2.2
(5)
3.7
(15)
Adh
Dhahirah
5.6
(9)
Ad
Dakhliyah
2.6
(7)
Al Wusta
0.0
(0)
Dhofar
6.8
(11)

Unknown (3)
www.moh.gov.om
39
1.5
(2)
1.9
(3)
Stomach
Stomach
Table 20: Gender Distribution of Gastric Cancer
Gender
Frequency
Crude
incidence
Age Standardized
incidence rate
Male
Female
Total
31
24
55
2.8
1.2
5.4
2.3
Figure 16 : Age-standardized incidence rates of stomach cancer in Oman and

(2010)
5
Note: Data of GCC countries are from 1998-2005; data of Algeria, UK, USA and Japan are from 1993-1997; For USA-white
Figure 17: Morphology of Stomach Cancer

Carcinoma NOS*
2%
Neoplasm
5%
Malignant
Lymphoma, nonHodgkins, NOS*
2%
Malignant
Lymphoma, large
Bcell diffuse
5%
Signetr
Signet ring cell
carcinoma
7%
Gastrointestinal
stromal sarcoma
4%
Burkitt lymphoma
NOS *
2%
www.moh.gov.om
Mucin-producing
adenocarcinoma
5%
Adenocarcinoma, NOS*
68%
40
Stomach
Figure 18 : Incidence of Cancer of the Stomach by Region

Musandam
(Sultanate of Oman)
4.6
(1)
Madha
(Sultanate of Oman)
3.4
(13)
1.3
(3)
Muscat
2.5
(10)
Adh
Dhahirah
1.3
(2)
Ad
Dakhliyah
3.4
(9)
Al Wusta
5.3
(1)
Dhofar
2.5
(4)

Unknown (0)
www.moh.gov.om
41
3.0
(4)
5.1
(8)
Breast
Figure 19: Morphology of Breast Cancer in Oman
Metaplastic
carcinoma, NOS*
1%
Malignant
lymphoma, large B-cell
diffuse, NOS*
1%
Papillary carcinoma
1%
Lobular carcinoma
2%
Malignant tumor, spindle

cell type
1%
Carcinoma,NOS*
2%
Medullary carcinoma
1%
Paget disease
mammary
1%
InOWUating duct
carcinoma,NOS*
90%
Figure 20: Age-standardized incidence rates of breast cancer in Oman and some
selected countries
(2010)
www.moh.gov.om
42
Breast
Figure 21 : Incidence of Breast Cancer by Region

Musandam
(Sultanate of Oman)
9.7
(1)
Madha
(Sultanate of Oman)
5.8
(11)
Muscat
13.1
(15)
23.0
(45)
Adh
Dhahirah
15.2
(12)
Ad
Dakhliyah
9.0
(12)
Al Wusta
10.9
(1)
Dhofar
16.4
(13)
Source : Ministry of National Economy

Unknown (0)
www.moh.gov.om
43
11.9
(8)
6.4
(5)

Table 21: Gender Distribution of Trachea, Bronchus and Lung Cancer
Gender
Frequency
Crude
incidence
Male
Female
Total
20
6
26
1.9
0.3
Age Standardized
incidence rate
4.2
0.7
Note : Incidence rates are per 100,000 per year
Figure 22 : Age-standardized incidence rates of trachea, bronchus and lung cancer in Oman and some selected countries
2010
Figure 23 : Morphology of Trachea, Bronchus and Lung Cancer

Other specied
carcer 4%
Unspecied
carcer 8%
2WKHUVSHFLHG
carcinoma12%
Small cell
carcinoma 12%
Squamous cell
carcinoma 22%
Unspecified
carcinoma 8%
Adenocarcinoma
34%
www.moh.gov.om
44
Figure 24 : Incidence of Trachea, Bronchus and Lung Cancer by Region

Musandam
(Sultanate of Oman)
4.6
(1)
Madha
(Sultanate of Oman)
2.4
(9)
Muscat
1.7
(7)
0.9
(2)
Adh
Dhahirah
0.6
(1)
Ad
Dakhliyah
0.0
(0)
Al Wusta
0.0
(0)
Dhofar
0.0
(0)

Unknown (1)
www.moh.gov.om
45
1.5
(2)
1.9
(3)
Urinary Bladder
Urinary Bladder
Table 22: Gender Distribution of Urinary Bladder Cancer
Gender
Frequency
Male
Female
Total
32
8
40
Crude
Age Standardized
incidence
incidence rate
3.3
0.4
6.7
0.7
Figure 25 : Age-standardized incidence rates of bladder cancer in Oman and

2010
10
15
20
25
30
Figure 26: Morphology of Urinary Bladder Cancer
Unspecied
carcinoma
5%
Unspecied cancer
3%
Transitional cell
carcinoma
92%
www.moh.gov.om
46
35
Urinary Bladder
Figure 27 : Incidence of Urinary Bladder Cancer by Region

Musandam
(Sultanate of Oman)
0.0
(0)
Madha
(Sultanate of Oman)
2.9
(11)
Muscat
2.6
(6)
1.5
(6)
Adh
Dhahirah
3.8
(6)
Ad
Dakhliyah
1.5
(4)
Al Wusta
0.0
(0)
Dhofar
1.2
(2)

Unknown (1)
www.moh.gov.om
47
1.5
(2)
1.3
(2)
Prostate
Prostate
Figure 28 : Age-standardized incidence rates of the prostate cancer in Oman and
2010
Figure 29: Morphology of Prostatic Cancer

Car
Carccinoma NOS*
17%
Papillary transitional
cell carcinoma
2%
Transitional cell
carcinoma
5%
Squamous cell
carcinoma NOS*
2%
Adenocarcinoma, NOS *
72%
Neoplasm
2%
*Not otherwise specied
www.moh.gov.om
48
Prostate
Figure 30 : Incidence of Prostatic Cancer by Region

Musandam
(Sultanate of Oman)
8.9
(1)
Madha
(Sultanate of Oman)
2.1
(4)
Muscat
5.1
(6)
5.3
(11)
Adh
Dhahirah
2.5
(2)
Ad
Dakhliyah
4.5
(6)
Al Wusta
0.0
(0)
Dhofar
Dhofar
6.0
6.0
(5)
(5)

Unknown (2)
www.moh.gov.om
49
4.5
(3)
1.3
(1)
Skin
Skin
Table 23 : Gender Distribution of Skin Cancer
Gender
Frequency
Male
Female
Total
28
24
52
Crude
Age Standardized
incidence
incidence rate
2.1
1.2
4.4
2.2
Figure 31: Age-standardized incidence rates of cancer of the skin in Oman and
2010
Figure 32: Morphology of Skin Cancer

Malignant lymphoma, large
B cell,diffuse,NOS*
2%
Malignant melanoma ,NOS*

6%
Dermato brosarcoma,NOS*
2%
Adenocarcinoma
2%
Synovial sarcoma,NOS*
2%
Malignant epithelioid
hemangioendothelioma
2%
Cutaneous T cell
lymphoma,NOS*
2%
Squamous cell carcinoma
21%
Hemangiosarcoma
2%
Malignant tumor gaint cell

type
2%
adinoid cystic carcinoma

2%
2%
Basal cell carcinoma
45%
Carcinoma,NOS*
2%
Kaposis sarcoma
6%
www.moh.gov.om
50
Skin
Figure 33 : Incidence of Skin Cancer by Region

Musandam
(Sultanate of Oman)
4.6
(1)
Madha
(Sultanate of Oman)
2.4
(9)
Muscat
2.2
(5)
4.2
(17)
Adh
Dhahirah
4.4
(7)
Ad
Dakhliyah
2.3
(6)
Al Wusta
5.3
(1)
Dhofar
1.2
(2)

The number in the brackets is the frequency
Unknown (0)
www.moh.gov.om
51
2.2
(3)
0.6
(1)
Colon
Colon
Table 24 : Gender Distribution of the Colon Cancer
Gender
Frequency
Male
Female
Total
29
11
40
Crude
Age Standardized
incidence
incidence rate
3
0.6
5.2
0.9
Figure 34: Age-standardized incidence rates of the colon cancer in Oman and some
selected countries
2010
5
Figure 35: Morphology of Colonic Cancer
Villous
adenocarcinoma
3%
Unspecified
carcinoma
5%
Carcinoid
tumor, NOS*
3%
Mucinous
adenocarcinoma
10%
79%
* Not otherwise specied

www.moh.gov.om
52
Colon
Figure 36 : Incidence of the Colon Cancer by Region

Musandam
(Sultanate of Oman)
0.0
(0)
Madha
(Sultanate of Oman)
1.0
(4)
Muscat
1.3
(3)
2.7
(11)
Adh
Dhahirah
2.5
(4)
Ad
Dakhliyah
1.5
(4)
Al Wusta
0.0
(0)
Dhofar
3.7
(6)

Unknown(3)
www.moh.gov.om
53
1.4
(2)
1.9
(3)
Rectum
Rectum
Table 25: Gender Distribution of the Rectum Cancer
Gender
Frequency
Male
Female
Total
9
15
24
Crude
Age Standardized
incidence
incidence rate
0.9
0.8
1.7
1.5
Figure 37: Age- Standardized incidence rate of the rectum cancer in

Oman and some selected countries
2010
Figure 38 : Morphology of Rectal Cancer

Mucinous
adenocarcinoma
4%
Neoplasm
4%
Verrucous
carcinoma, NOS*
4%
Signet ring cell

carcinoma
4%
Adenocarcinoma,
NOS*
70%
www.moh.gov.om
54
Rectum
Figure 39 : Incidence of Rectum Cancer by Region

Musandam
(Sultanate of Oman)
0.0
(0)
Madha
(Sultanate of Oman)
0.3
(1)
Muscat
1.3
(3)
Adh
Dhahirah
1.2
(5)
0.6
(1)
Ad
Dakhliyah
1.1
(3)
Al Wusta
0.0
(0)
Dhofar
1.2
(2)

Unknown(1)
www.moh.gov.om
55
2.2
(3)
3.2
(5)
Bone
Bone
Table 26: Gender Distribution of Bone Cancer
Gender
Frequency
Male
Female
Total
14
4
18
Crude
Age Standardized
incidence
incidence rate
1.2
0.2
1.3
0.2
Figure 40: Age-standardized incidence rates of bone cancer in Oman and some
selected countries
2010
Figure 41 : Morphology of Bone Cancer
Osteosarcoma
28%
Other specified cancer

22%
Unspecified cancer
6%
Ewings sarcoma
38%
Fibrosarcoma
6%
www.moh.gov.om
56
Bone
Figure 42 : Incidence of Bone Cancer by Region

Musandam
(Sultanate of Oman)
0.0
(0)
Madha
(Sultanate of Oman)
1.8
(7)
Muscat
0.0
(0)
0.2
(1)
Adh
Dhahirah
0.0
(0)
Ad
Dakhliyah
1.1
(3)
Al Wusta
5.3
(1)
Dhofar
1.9
(3)

Unknown(1)
www.moh.gov.om
57
0.7
(1)
0.6
(1)
Thyroid
Thyroid
Table27: Gender Distribution of Thyroid Cancer
Gender
Frequency
Male
Female
Total
2
33
35
Crude
Age Standardized
incidence
incidence rate
0.2
1.7
0.4
2.2
Figure 43: Age-standardized incidence rates of thyroid cancer in Oman and some
selected countries
2010
5
Figure 44 : Morphology of Thyroid Cancer

UnspeFLHG
cancer
3%
Other VSHFLed
carcinoma
6%
UnspeFLHG
carcinoma
3%
Follicular
carcinoma
3%
Pappillary
carcinoma
85%
www.moh.gov.om
58
Thyroid
Figure 45 : Incidence of the Thyroid Cancer by Region

Musandam
(Sultanate of Oman)
0.0
(0)
Madha
(Sultanate of Oman)
1.0
(4)
Muscat
0.9
(2)
2.7
(11)
Adh
Dhahirah
3.1
(5)
Ad
Dakhliyah
1.1
(3)
Al Wusta
0.0
(0)
Dhofar
3.1
(5)

Unknown(1)
www.moh.gov.om
59
1.5
(2)
1.3
(2)
Leukemia
Leukemia
Table 28: Gender Distribution of Leukemia
Gender
Frequency
Male
Female
Total
35
24
59
Crude
Age Standardized
incidence
incidence rate
3.5
1.2
4.2
1.5
Figure 46 : Age-standardized incidence rates of luekemia in Oman and some

selected countries
2010
Chronic lymphoid
leukemia
2%
Figure 47 : Morphology of Leukemia

Other specied
lymphoid leukemia
27%
Acute lymphoid
leukemia
15%
UnspHFLHG leukemia
7%
www.moh.gov.om
Acute myeloid
leukemia
28%
Chronic myeloid
leukemia
15%
Other specied acute

leukemia
3%
60
Unspecied myeloid
leukemia
3%
Leukemia
Figure 48 : Incidence of Leukemia by Region

Musandam
(Sultanate of Oman)
0.0
(0)
Madha
(Sultanate of Oman)
2.6
(10)
Muscat
4.3
(10)
3.2
(13)
Adh
Dhahirah
3.8
(6)
Ad
Dakhliyah
2.6
(7)
Al Wusta
0.0
(0)
Dhofar
4.9
(8)

Unknown (2)
www.moh.gov.om
61
1.5
(2)
0.6
(1)
Brain and Nervous System

Table 29: Gender Distribution of Brain and Nervous System Cancer
*HQGHU
)UHTXHQF\
Male
)HPDOH
Total
19
16
35
&UXGH
$JH6WDQGDUGL]HG
LQFLGHQFH LQFLGHQFHUDWH
1.6

2
1
1RWH,QFLGHQFHSHUSHU\HDU
Figure 49: Age-standardized incidence rates of cancer of the brain and nervous
system cancer in Oman and some selected countries
2010
Note:'DWDRI*&&FRXQWULHVDUHIURPGDWDRI Algeria, UK, USADQG-DSDQDUHIURP)RU86$ZKLWH

SRSXODWLRQGDWDZDVXVHG
Figure 50 : Morphology of Brain and Nervous System Cancer

Other VSHFLHGtumours
16%
UnspecLHG tumours
3%
Tumours off cranial
T
i l
nerves
3%
Astrocytic tumourstumours
gliomas
36%
Soft tissue tumour

3%
Meningoma
6%
Other embryonal tumours
6%
2OLJRGeQGURJOLDO tumours
DQG mixHGJOLomas
MHGXOORblastoma
9%
9%
www.moh.gov.om
62
Gliomas of uncertain
origin
(SHQGymal tumours
6%
3%
Figure 51 : Incidence of Brain and Nervous System Cancer by Region

Musandam
(Sultanate of Oman)
0.0
(0)
Madha
(Sultanate of Oman)
1.3
(5)
Muscat
0.4
(1)
2.7
(11)
Adh
Dhahirah
1.3
(2)
Ad
Dakhliyah
2.6
(7)
Al Wusta
5.3
(1)
Dhofar
1.9
(3)

Unknown(0)
www.moh.gov.om
63
0.7
(1)
2.6
(4)
Cervix
Cervix
Figure 52 : Age-standardized incidence rates of the cervix cancer in Oman and
2010
Figure 53 : Morphology of the Cervix Cancer

Unspecified
cancer
3%
Adenocarcinoma,
34%
Squamous cell
carcinoma
63%
www.moh.gov.om
64
Cervix
Figure 54 : Incidence of Cervical Cancer by Region

Musandam
(Sultanate of Oman)
0.0
(0)
Madha
(Sultanate of Oman)
2.6
(5)
Muscat
4.4
(5)
5.1
(10)
Adh
Dhahirah
3.8
(3)
Ad
Dakhliyah
3.8
(5)
Al Wusta
10.9
(1)
Dhofar
1.3
(1)

Unknown(0)
www.moh.gov.om
65
3.0
(2)
3.9
(3)
Liver
Liver
Table 30: Gender Distribution of Liver Cancer
Gender
Frequency
Male
Female
Total
16
14
30
Crude
Age Standardized
incidence
incidence rate
1.5
0.7
3.1
1.5
Figure 55: Age-standardized incidence rates of the liver cancer in Oman and
Oman ( 2010)
Note:
Data of GCC countries are from 1998-2005; data of Algeria, UK, USA and Japan are from 1993-1997; For USA-white
Figure 56 : Morphology of Liver Cancer

Hepatoblastoma
10%
Other specied
carcinoma
10%
Hepatocellular
carcinoma
70%
Other sarcoma
3%
Unspecied
carcinoma
3%
Cholangiocarcinoma
40%
www.moh.gov.om
66
Liver
Figure 57 : Incidence of Liver Cancer by Region

Musandam
(Sultanate of Oman)
0.0
(0)
Madha
(Sultanate of Oman)
1.6
(6)
Muscat
1.7
(4)
2.2
(9)
Adh
Dhahirah
0.0
(0)
Ad
Dakhliyah
1.1
(3)
Al Wusta
0.0
(0)
Dhofar
3.7
(6)

Unknown(0)
www.moh.gov.om
67
0.0
(0)
1.3
(2)
Esophagus
Esophagus
Table 31 : Gender Distribution of Esophagus Cancer
Gender
Frequency
Male
Female
Total
13
5
18
Crude
Age Standardized
incidence incidence rate
1.3
0.3
2.9
0.5
Figure 58: Age-standardized incidence rates of the esophagus cancer in Oman

and some selected countries
2010
Figure 59 : Morphology of Esophageal Cancer

Unspecified cancer
6%
Squamous cell
carcinoma
39%
Adenocarcinoma
55%
www.moh.gov.om
68
Esophagus
Figure 60 : Incidence of Esophageal Cancer by Region

Musandam
(Sultanate of Oman)
0.0
(0)
Madha
(Sultanate of Oman)
1.0
(4)
Muscat
0.9
(2)
0.5
(2)
Adh
Dhahirah
1.3
(2)
Ad
Dakhliyah
1.1
(3)
Al Wusta
0.0
(0)
Dhofar
1.9
(3)

Unknown(0)
www.moh.gov.om
69
0.0
(0)
1.3
(2)
Kidney and Ureter

Kidney and Ureter
Table 32: Gender Distribution of the Kidney & Ureter Cancer
Gender
Frequency
Male
Female
Total
16
9
25
Crude
Age Standardized
1.5
0.5
2.7
0.7
Figure 61 : Age-standardized incidence rates of the kidney cancer in Oman and

2010
Figure 62 : Morphology of Kidney and Ureter Cancer

Nephroblastoma
12%

4%
Squamous cell carcinoma

12%
Renal cell carcinoma
72%
www.moh.gov.om
70
Kidney and Ureter
Figure 63 : Incidence of Kidney and Ureter Cancer by Region

Musandam
(Sultanate of Oman)
0.0
(0)
Madha
(Sultanate of Oman)
0.8
(3)
Muscat
1.3
(3)
1.2
(5)
Adh
Dhahirah
0.0
(0)
Ad
Dakhliyah
2.6
(7)
Al Wusta
5.3
(1)
Dhofar
2.5
(4)

Unknown(0)
www.moh.gov.om
71
0.7
(1)
0.6
(1)
Pancreas
Pancreas
Table 33: Gender Distribution of the Pancreas Cancer
Gender
Frequency
Male
Female
Total
11
3
14
Crude
Age Standardized
1.1
0.2
2.4
0.3
Figure 64: Age-standardized incidence rates of the pancreas cancer in Oman and
2010
Figure 65 : Morphology of Pancreatic Cancer

Papillary
carcinoma, NOS*
7%
Neoplasm
21%
72%
www.moh.gov.om
72
10
Pancreas
Figure 66 : Incidence of Pancreatic Cancer by Region

Musandam
(Sultanate of Oman)
0.0
(0)
Madha
(Sultanate of Oman)
0.3
(1)
Muscat
0.5
(2)
0.4
(1)
Adh
Dhahirah
0.0
(0)
Ad
Dakhliyah
0.4
(1)
Al Wusta
0.0
(0)
Dhofar
2.5
(4)

Unknown(2)
www.moh.gov.om
73
0.7
(1)
1.3
(2)
Ovary
Ovary
Figure 67: Age-standardized incidence rates of the ovary cancer in Oman and
2010
Figure 68 : Morphology of Ovarian Cancer
Unspecified
cancer
19%
Germ cell tumors

19%
Other
specified
carcinoma
13%
Serous carcinoma*
25%
Endometriod
carcioma
12%
Clear cell carcinoma

6%
www.moh.gov.om
74
Mucinous carcinoma*
6%
Ovary
Figure 69 : Incidence of Ovarian Cancer by Region

Musandam
(Sultanate of Oman)
0.0
(0)
Madha
(Sultanate of Oman)
1.1
(2)
Muscat
1.7
(2)
1.5
(3)
Adh
Dhahirah
1.3
(1)
Ad
Dakhliyah
1.5
(2)
Al Wusta
0.0
(0)
Dhofar
2.5
(2)

Unknown(0)
www.moh.gov.om
75
4.5
(3)
1.3
(1)
Larynx
Larynx
Table 34: Gender Distribution of the Larynx Cancer
Gender
Frequency
Male
Female
Total
11
1
12
Crude
Age Standardized
1.1
0.1
2.3
0.1
Figure 70: Age-standardized incidence rates of the larynx cancer in Oman and
2010
Figure 71 : Morphology of Laryngeal Cancer

Giant cell carcinoma
8%
Spindle cell
carcinoma,NOS*
8%
Carcinoma ,NOS*
8%
Squamous cell
carcinoma, NOS
68%
Neoplasm
8%

www.moh.gov.om
76
Larynx
Figure 72 : Incidence of Laryngeal Cancer by Region

Musandam
(Sultanate of Oman)
0.0
(0)
Madha
(Sultanate of Oman)
1.0
(4)
Muscat
0.4
(1)
0.5
(2)
Adh
Dhahirah
0.6
(1)
Ad
Dakhliyah
0.0
(0)
Al Wusta
0.0
(0)
Dhofar
0.6
(1)

Unknown(0)
www.moh.gov.om
77
0.7
(1)
1.3
(2)
Uterus
Uterus
Figure 73: Age-standardized incidence rates of the uterus cancer in Oman and
2010
Figure 74 : Morphology of Uterine Cancer

27%
Adenocarcinoma
67%
Unspecified carcinoma
6%
www.moh.gov.om
78
Uterus
Figure 75 : Incidence of Uterine Cancer by Region

Musandam
(Sultanate of Oman)
0.0
(0)
Madha
(Sultanate of Oman)
0.5
(1)
Muscat
0.9
(1)
2.6
(5)
Adh
Dhahirah
0.0
(0)
Ad
Dakhliyah
0.0
(0)
Al Wusta
0.0
(0)
Dhofar
6.3
(5)

The number in the brackets is the frequency
Unknown(0)
www.moh.gov.om
79
3.0
(2)
1.3
(1)
Childhood Cancers
www.moh.gov.om
82
Childhood Cancers
Childhood Cancers
Of the 876 cases reported in Omanis during 2010, 60 cases were among children aged
14 years and below, constituting 6.85% of the total cancers reported.
Table 35: Frequency of Five Common Cancers in Omani Children
Topography
Frequency
Percentage (%)
Lymphoid leukemias
15
25
Neuroblastoma
11.7
Ewing Sarcoma
6.7
Acute myeloid leukemias, NOS *
6.7
Hodgkin lymphomas
6.7
Table 36: Frequency of Five Common Cancers in Omani Boys

Topography
Frequency
Percentage (%)
Lymphoid leukemias
19.4
Neuroblastoma
11.1
Acute myeloid leukemias, NOS*
8.3
Malignant lymphomas,Non-Hodgkin,NOS*
5.6
Medulloblastoma,NOS *
5.6
www.moh.gov
www
.moh.gov.om
83
www.moh.gov.om
84
10
15
20
Lymphoid
leukemias
15
Neuroblastoma
Ewing Sarcoma
Acute myeloid
leukemias,NOS
Hodgkin Lymphomas
Figure 79 : Frequency Distribution of Common Cancers in Omani Children 2010
Childhood Cancers
Frequency
Childhood Cancers
Table 37: Frequency of Five Common Cancers in Omani Girls

Topography
Frequency
Percentage (%)
Lymphoid leukemias
33.3
Hodgkin Lymphoma
12.5
Neuroblastoma
12.5
Ewing Sarcoma
8.3
Acute myeloid leukemias,NOS *
4.2
www.moh.gov.om
85
www.moh.gov.om
Retinoblastoma
2
2
-
4
4
-
86
2
2
2
2
-
2
2
-
4
4
-
4
2
-
1
1
-
1
1
-
2
-
2
-
2
-
12
8
3
-
3
2
-
4
3
1
-
5
3
2
-
10 - 14 Total
5-9
0-4
6.0
6.0
0.0
0.0
6.0
6.0
0. 0
0.0
5.6
5.6
0.0
0.0
5.6
5.6
0. 0
0.0
0.0
0.0
11.3
11.3
0.0
12.1
12.1
0.0
0.0
0.0
0.0
11.3
0.0
5.6
0.0
0.0
0.0
0.0
5.6
0.0
5.6
0.0
11.3
0.0
2.8
33.9
22.6
8.5
0.0
0.0
12.1
0.0
6.0
0.0
0.0
0.0
0.0
6.0
0.0
6.0
0.0
12.1
0.0
3.0
36.2
24.1
9.0
0.0
1
1
-
1
1
3
3
-
2
1
1
4
2
2
-
0-4
1
-
2
2
- 2
-
5-9
1
1
-
2
-
3
3
-
1
1
-
1
1
3
3
-
3
1
1
1
3
-
9
7
10 - 14 Total
0.0
0.0
0.0
0.0
2.8
2. 8
0. 0
0.0
2.8
2.8
8.5
8.5
0.0
0.0
8.5
2.8
0.0
0.0
2.8
0.0
2.8
8.5
0.0
0.0
0.0
8.5
0.0
0.0
25.5
19.9
5.7
0.0
0.0
0.0
0.0
0.0
2.5
2.5
0. 0
0.0
2.5
2.5
7.5
7.5
0.0
0.0
7.5
2.5
0.0
0.0
2.5
0.0
2.5
7.5
0.0
0.0
0.0
7.5
0.0
0.0
22.5
17.5
5.0
0.0
Table 38 : Frequency Distribution of Childhood Cancers in Oman, 2010 (International Classication of Childhood Cancers)
Childhood Cancers
1
-
www.moh.gov.om
1
2
1
1
-
87
0.0
2.8
0.0
0.0
0.0
0.0
3.0
0.0
0.0
1
10
18
36
108.6
0.0
0.0
101.6
0.0
0.0
0.0
2.8
0.0
0.0
1
-
3.0
0.0
0.0
1
-
1
-
2.8
2.8
0.0
0.0
12
1
1
5.6
0.0
3.0
3.0
0.0
0.0
0.0
5.6
0.0
0.0
0.0
5.6
8.5
2.8
0.0
5.6
0.0
0.0
6.0
0.0
0.0
6.0
0.0
0.0
0.0
6.0
9.0
3.0
0.0
6.0
0.0
0.0
2
-
2
-
3
1
2
-
3
1
1
1
2
-
1
-
1
-
24
1
1
-2
1
3
-
68.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
2.8
2.8
0.0
0.0
0.0
0.0
0.0
0.0
0.0
5.7
0.0
2.8
8.5
0.0
59.9
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
2.5
2.5
0.0
0.0
0.0
0.0
0.0
0.0
0.0
5.0
0.0
2.5
7.5
0.0
Childhood Cancers
Cancer among
Non-Omanis
Cancer among Non-Omanis

Table 39: Gender Distribution of Cancer Cases among Non-Omanis
Gender
Frequency
Male
34
Female
39
Total
73
Table 40: Five Most Common Cancers in Non-Omanis (Males & Females)
Topography
Frequency
Percentage (%)
Breast
21
28.8
Skin
9.6
Leukemia
8.2
Colon
6.9
Liver
4.1
Table 41: Five Most Common Cancers in Non-Omanis (Males)

Topography
Frequency
Percentage (%)
Leukemia
11.8
Skin
11.8
Colon
8.8
Liver
8.8
Tongue
5.9
www.moh.gov.om
90
Table 42: Five Most Common Cancers among Non-Omanis (Females)

Topography
Frequency
Percentage (%)
Breast
21
53.8
Uterus
7.7
Skin
7.7
Leukemia
5.1
Colon
5.1
Table 43: Regional Distribution of Cancer Cases among Non-Omanis

Region
Frequency
Al Wusta
Ad Dakhliyah
Adh Dhahirah
Dhofar
Musandam
Muscat
41
North Al Batinah
North Ash Sharqiyah
South Al Batinah
South Ash Sharqiyah
Unknown
Total
3
73
www.moh.gov.om
91
Table 44: Distribution of Cancer Cases among Non-Omanis by Nationality

Country
Frequency
India
14
Egypt
Sudan
UK
Yemen
Pakistan
Philippines
South Africa
Bangladesh
Iraq
Jorden
United Republic of Tanzania
Lebanon
Saudi Arabia
Russian Federation
Indonesia
Canada
Somalia
Australia
Unknown
Total
73
www.moh.gov.om
92
Deaths Due to Cancer
Cancer Mortality
Table 47: Hospital-based Deaths Due to Cancer in 2010
Malignant neoplasm of lip, oral cavity, pharynx & esophagus

Malignant neoplasm of stomach
Malignant neoplasm of other sites of digestive organs
Malignant neoplasm of colon
Malignant neoplasm of rectum, rectosigmoid junction and anus
Malignant neoplasm of liver & intraheptic bile ducts
Malignant neoplasm of pancreas
Malignant neoplasm of other respiratory & intrathoracic organs
Malignant neoplasm of larynx
Malignant neoplasm of trachea, bronchus and lung
Malignant neoplasm of bone & articular cartilage
Other malignant neoplasms of mesothelial and soft tissue
Malignant neoplasm of breast
Malignant neoplasm of other female genital organs
Malignant neoplasm of cervix uteri
Malignant neoplasm of other & unspecied parts of uterus
Malignant neoplasm of prostate
Other malignant neoplasm of urinary Tract
Malignant neoplasm of urinary bladder
Malignant neoplasm of eye & adnexa
Malignant neoplasm of other parts of central nervous system
Malignant neoplasm of brain
Malignant neoplasm of thyroid & endocrine glands
Malignant neoplasm of ill-dened, secondary & unspecied sites
Hodgkins diseases
Non Hodgkins lymphoma
Other malignant neoplasm of lymphatic & haemopoietic tissue
Leukemia
Other In situ neoplasams
Carcinoma in citu of Cervix Uteri
Other benign neoplasm
Benign neoplasm of Uterus
Neoplasams of uncertain or unknown behavior
TOTAL
Male
10
21
3
14
0
10
10
1
4
27
2
1
0
0
0
0
12
2
4
0
1
11
1
12
1
9
3
5
11
0
2
0
6
183
Female
8
17
5
6
3
16
10
3
0
4
1
0
29
7
3
6
0
1
2
1
2
5
4
16
0
3
1
2
6
1
2
1
5
170
Total
18
38
8
20
3
26
20
4
4
31
3
1
29
7
3
6
12
3
6
1
3
16
5
28
1
12
4
7
17
1
4
1
11
353
Note: The above data are deaths of cancer patients, which occurred in hospitals of the Ministry of Health
only.
www.moh.gov.om
93
www.moh.gov.om
94
Cancer Incidence in
Five Continents
www.moh.gov.om
95
Cancer Incidence in Five Continents

This book is the reference source for
cancer incidence in many countries
and populations. Registries whose
data was of good quality was accepted
for inclusion in this book by IARC.In
addition to detailed information on cancer
incidence, it provides information on some
demographic characteristics, coding and
registration practices of each registry and
incidence rates by population and site of
cancer. Data from some Arab countries
have been included in the publication. Two
new additions in this volume are data from
Bahrain and Tunisia.
The efforts of the Oman National Cancer

Registry bore fruit when data from the
registry was included in the publication of
the International Agency for Research on
Cancer (IARC) entitled Cancer Incidence
in Five Continents, Volume 9. This book
is published every ve years. This is the
second consecutive time that Omans
data has been accepted for inclusion in
this book, the previous edition being ve
years ago in 2002. The present edition is
available online at the following URL
http://www-dep.iarc.fr
The previous edition, Cancer Incidence in
Five Continents, Volume 8, was originally
printed as a hard copy but is now available
online at the same URL given above.
www.moh.gov.om
A copy of the screen of http://www-dep.

iarc.fr is shown on the next page as well
as a copy of Omans data from the prevous
volume of Cancer Incidence in Five
Continents following this.
96
www.moh.gov.om
97
Abstract from IARC Scientic Publications No. 155
www.moh.gov.om
98
www.moh.gov.om
99

*OMAN: OMANI (1998-2001)
MALE
No. Freq
Cases (%)
Lip
Tongue
Mouth
Salivary glands
Tonsil
Other oropharynx
Nasopharynx
Hypopharynx
Pharynx unspecitied
Oesophagus
Stomach
Small intestine
Colon
Rectum
Anus
Liver
Gallbladder etc.
Pancreas
Nose,sinuses etc.
Larynx
Lung (incl. trachea and
other thoracic organs
Bone
Melanoma of skin
Other Skin
Mesothelioma
Kaposi sarcoma
Connextive and soft tissue
Breast
Vulva
Vargina
Cervix uteri
Corpus uteri
Uterus unspecitied
Ovary
Other female genital organs
Placenta
Penis
Prostate
Testis
Other male genital organs
Kidney
Renal pelvis
Ureter
Bladder
Other urinary organs
Eye
Brain, nervous system
Thyroid
Adrenal gland
Other endocrine
Hodgkin disease
Immunoproliterative diseases
Multiple myeloma
Lymphoid leukaemia (C91)
Myleod leukaemia
Leukaemia unspecied
Myloproliterative disorders
Myloproliterative syndromes
Other and Unspecied
All Sites
All sites but skin
www.moh.gov.om
8
16
16
8
2
2
20
5
0
41
219
5
46
37
11
124
12
34
6
22
160
8
18
6
69
5
8
38
15
0
166
12
0
32
1
1
85
3
12
87
32
3
2
78
161
1
34
77
54
20
0
0
106
1928
1859
0.4
0.8
0.8
0.4
0.1
0.1
1.0
0.3
0.0
2.1
11.4
0.3
2.4
1.9
0.6
6.4
0.6
1.8
0.3
1.1
8.3
0.4
0.9
0.3
3.6
0.3
0.4
2.0
0.8
0.0
8.6
0.6
0.0
1.7
0.1
0.1
4.4
0.2
0.6
4.5
1.7
0.2
0.1
4.0
8.4
0.1
1.8
4.0
2.8
1.0
0.0
0.1
5.5
100.0
96.4
FEMALE
Crude rate ASR World

Per 100,000
0.2
0.4
0.4
0.3
0.1
0.1
0.6
0.1
0
1.1
6.1
0.1
1.3
1
0.3
3.5
0.3
1
0.2
0.6
4.5
0.2
0.5
0.2
1.9
0.1
0.2
1.1
0.4
0
4.7
0.3
0
0.9
0
0
2.4
0.1
0.3
2.4
0.9
0.1
0.1
2.2
4.5
0
1
2.2
1.5
0.6
0
0
3
54
52.1
0.5
0.9
0.9
0.4
0.1
0.1
1
0.2
0
2.6
13.4
0.3
2.5
2.1
0.7
7.4
0.7
2.1
0.4
1.4
9.8
0.4
0.7
0.4
4.2
0.3
0.5
1.4
0.9
0
10.5
0.4
0
1.7
0.1
0.1
5.1
0.2
0.5
3.5
1.7
0.1
0.1
2.8
8.2
0.1
2
2.4
2.4
0.7
0
0
6.1
105.1
100.9
100
No. Freq
Cases (%)
1
6
9
7
0
0
7
6
1
41
99
4
37
24
1
53
17
25
3
6
36
1
16
6
70
1
7
22
265
3
6
108
14
22
111
0
4
34
0
1
36
0
12
67
137
9
1
33
93
0
28
47
42
20
1
0
97
1967
1627
0.1
0.4
0.5
0.4
0.0
0.0
0.4
0.4
0.1
2.4
5.8
0.2
2.2
1.4
0.1
3.1
1.0
1.5
0.2
0.4
2.1
0.1
0.9
0.4
4.1
0.1
0.4
1.3
15.6
0.2
0.4
6.4
0.8
1.3
6.5
0.0
0.2
2.0
0.0
0.1
2.1
0.0
0.7
3.9
8.1
0.5
0.1
1.9
5.5
0.0
1.6
2.8
22.5
1.2
0.1
0.0
5.7
100.0
95.9
Crude rate ASR World

Per 100,000
0
0.2
0.3
0.2
0
0
0.2
0.2
0
1.2
2.9
0.1
1.1
0.7
0
1.5
0.5
0.7
0.1
0.2
1
0
0.5
0.2
2
0
0.2
0.6
7.7
0.1
0.2
3.1
0.4
0.6
3.2
0
0.1
1
0
0
1
0
0.3
1.9
4
0.3
0
1
2.7
0
0.8
1.4
1.2
0.6
0
0
2.8
49.2
47.2
0.1
0.4
0.5
0.3
0
0
0.3
0.3
0.1
2.7
6.2
0.3
2.2
1.4
0.1
3.2
1.1
1.6
0.1
0.3
2.3
0
0.4
0.3
4.2
0.1
0.4
0.8
14.6
0.2
0.3
6.5
0.9
1.2
6.2
0
0.2
1.6
0
0
2.2
0
0.5
2.6
5.9
0.3
0
1.3
4.4
0
1.9
1.5
1.8
0.7
0.1
0
5.8
90.7
86.5
ICD-10
C00
C01-02
C03-06
C07-08
C09
C10
C11
C12-13
C14
C15
(C16)
C17
C18
C19-20
C21
C22
C23-24
C25
C30-31
C32
C33-34
C37-38
C40-41
C43
C44
C45
C46
C47+C49
C50
C51
C52
C53
C54
C55
C56
C57
C58
C60
C61
C62
C63
C64
C65
C66
C67
C68
C69
C70-72
C73
C74
C75
C81
C82-85, C-96
C88
C90
C91
C92-94
C95
MPD
MDS
0&U
ALL
ALLbC44
Members of the National Cancer Control Committee
www.moh.gov.om
101
www.moh.gov.om
103
www.moh.gov.om
106
www.moh.gov.om
107
dG IQGRh
Y S
Y S WdG hM e
2010 Y jJ
OGYEG
L Y.O
JGdG MCG OGL .O
JGdG eCGY A .O
HdG OM f
HQdG Y MV
dG hDd edG jjG

jG Z VGeCG aeh bGe IFGO
ee
eGj dGh 2010 d Y WdG hM Y eG dG `` jdG `` bCG CG `` j
.G hdG hd dG AGQRh LG OfG e
Y e gh dG ad `` SSCG dG j WdG Ea dG `` dG e `` fd `` ah
EG H adG JJ CG bG eh (adG ac e %13 GM ) 2008 dG Iah dM e 7^6
Fbh JGSG `` J N e `` adG g N h , 2030 `` Y H I`` ah `` dM `` e 11
dG GdG `` j WdG c .`` VH HG Yh G `` dG N eh `` dOCG `` Y `` Fb
.Y Iad jODG FdG SCG ddG JG VG
ic eY U e BG M j WdG CG EG J dG HdG `` FdG jdG G`` g `` cDj
dG hH fQe VfG cCG `` G e IMGh hJ dG ah dG Q`` fG `` e CG PEG `` Y
e GJ fCG EG VG dG GdG N dG WS M jGJ e ZdG Yh .YdG
G S a , 1hdG hd NCG jdG dd QTCG c G hdG hH fQe
d 15^7 `H fQe `` f 100^000 d 54^4 jdG `` dG ah G dG WS Q`` fG `` e `` j
.Y f 100^000
dG `` HEG fhd dG `` SDG `` edG AedG `` ad `` dH `` JCG CG `` j
Gh jQGOEGh `` MdGh dG G `` edG L j CG eBGh `` WdG `` H `` WdG
J IO`` L LCG e `` Y JMeh JM `` Mf c , `` jdG Gg `` Y `` WEG `` e
Y WdG
H L H Y .O
WdG a WdG dG FQ
dG dG Qe
2007-1998 hdG hO WdG V HUEG e -1
jG
jG
10 ....................................................................................................................................................aGL FN
10 ........................................................................................................................................................fS FN
11 ..................................................................(2010 e Qe g c ) dGh dG M dG jRJ
11 ............................................................... (2010 e Qe g c) dGh G M dG jRJ
12 ................................................................................................................................ Wd WdG dG jQCJ
12 ....................................................................................................................................................... fdG L -1
12 ................................................................................................................................................... dG G (CG
12 ............................................................................................................................................... dG HEG (
12 .....................................................................................................................dNOEGh bJh fdG J -2
13 ................................................................................................................................................. fdG SG -3
13 ..................................................................................................................................................... fdG -4
14 ............................................................................................................................................................... jJ -5
16 ........................................................................................................................................................... edG FdG
16 .................................................................................................... G M Y WdG M jRJ
16 ................................................................................................ d ah fdG H WdG M jRJ
16 ................................................................... 2010 Y N fEGh QcdG fdG H fWS Y gCG
17 ...................................................................... 2010 Y N QcdG fdG H FT fWS Y gCG
17 ..................................................................... 2010 Y N fEG fdG H YT fWS Y gCG
20 ............................................................................ 2010 Y N QcdG fdG H WdG M OY
21 .............................................................................. 2010 Y N fEG fdG H WdG M OY
22 ...................................... 2010 Y N Y dCG Fe d QcdG fdG H WdG hM e
23 ........................................ 2010 Y N Y dCG Fe d fEG fdG H WdG hM e
24 .......................................................... 2010 G 1998 e (QcdG) fdG H WdG M gG
E fdG H WdG M gG
25 ............................................................ 2010 EG 1998 e (fG)
26 ..................... 2010-1998 Y dCG Fe d (QcdG) fdG H WdG hM e gG
27 ....................... 2010-1998 fY dCG Fe d (fEG) fdG H WdG hM e gG
28 ........................................................................................................................................... WdG J W
29 ............................................................................................................................................................ dG WS
31 ..................................................................................................................................................... WCG fWS
33 .............................................................................. (fEGh QcP) fdG WCG H FdG fWdG gCG
33 ..................................................................................... (QcdG) fdG WCG H FdG fWdG gCG
33 ..................................................................................... (fEG) fdG WCG H FdG fWdG gCG
C QcP)fdGWG
C fWdQGdGjRdG
34 (WCGfWdhdGdG)2010YN(fGh
```èe
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
fEG (%)
2010 dG d dG dG
QcP (%)
```èe
IdG dG WG Vj Y d J SQ
jG e
WdG T
WdG L
bdG T
bdG L
IgdG
NGdG
bdG
SdG
QX
dG
. dhdG OhH j a dG SdG GH NDj dch dG IQGRH UN jQGOEG J g NGdG dG . jdG Gg OGYEG M ae j dG a QGOEG dG
`````èe
aGL FN
dG ah .jh 61 J (1T) We T e bdG G bCG Y S J
.e ah QX ah e a :g ec 1^700 ae MGS h HdG IjG
IgdGh WdGh bdGh NGdG :a WG eCG NG gOhM Mh dG eg e e
e c bo ,dG IQGOEG VGZCh .SdGh g QH KK Y Jh G dG jQ
U e EG WdGh bdG e e g .dG Hh Y Nh HdG G
.We IY dG WG OY d HdG GQeEG dhOh jOdG HdG G dG
e dG h dG jQL G EGh ,IG
fS FN MS Hjh .dG H dG e gjh eg
ObEG IQGRh e QOdG FMEG jd ah Ie IjL gCG e fdG QG e GOY Y
.fG QLh
2003 d dG OGdG Y G 2010 d WdG
f 2,749,734 H Y S dG OY Ea IjG T dhO cCG K g Y Sh
e816,143 h fY 1,933,591 e (1 hG) ec dCG 309 GM Me J PEG ,HdG
G dG f J .(jaGh) fdG Z e J dG VGQCG W NH Jh .He
WCG f Jh ,cP 1000 d fCG 975 G dG e dG WG Jh .dGh jOdGh G
WCG f J H %13^46dG e eG hO dG Hh Y N Y J M WG gCG
j jdG eCG %35^28dG e Y eG hO J H Y Me LEG e %3 ``gh
% 5^17 G f a dG e cCa eY S VGQCG LEG e %15 QJ Me G WG
fd dG jRdG (2 hG) Vjh .a eCG ,dG LEG e %5 GM jh dH
M eGSG e gh ,dGh bEG M jhGdG WGh jOhCG J a VGQCG bH
WG WdG hM e G jh .dG VGQCG LEG e %82 h
WG kWQh kGQM j M ,iNC e e
GY e NGdG WG kaL kGQMh ,kU MdG
e H J dG QX ah JG G
.dG GW
Nh a HQCG EG jQGOEG Y S J
10
`````èe
(2010e Qe g c ) dGh dG M dG jRJ :1 hL

G
%
OdG
13^46 260^331
10^93 211^267
10^90 210^723
12^46 240^988
12^29 237^574
10^53 203^679
7^81
150^988
5^18
100^203
3^73
72^129
3^03
58^588
2^66
51^487
1^85
35^715
1^66
32^070
1^16
22^453
1^06
20^568
1^28
24^828
100^00 1^933^591
fEG
%
13^34
10^87
10^79
12^29
12^13
10^62
7^94
5^18
3^77
3^11
2^85
1^96
1^67
1^14
0^99
1^34
100^00
QcP
OdG
127^423
103^849
103^056
117^382
115^848
101^433
75^806
49^461
36^025
29^717
27^205
18^747
15^923
10^916
9^484
12^843
955^018
%
13^58
10^98
11^00
12^63
12^44
10^45
7^68
5^19
3^69
2^95
2^48
1^73
1^65
1^18
1^13
1^24
100^00
OdG
132^908
107^418
107^667
123^606
121^726
102^206
75^182
50^742
36^104
28^871
24^282
16^968
16^147
11^537
11^084
12^085
978^573
jdGdG
4-0
9-5
14-10
19-15
24-20
29-25
34-30
39-35
44-40
49-45
54-50
59-55
64-60
69-65
74-70
+75
G
(2010 e Qe g c) dGh G M dG jRJ :2 hL

G
fEG
QcdG
18^817
265^805
159^944
162^083
21^633
402^066
381^842
134^459
231^569
155^373
1^933^591
9^181
132^987
78^809
79^080
10^361
195^543
189^120
67^382
114^693
77^862
955^018
9^636
132^818
81^135
83^003
11^272
206^523
192^722
67^077
116^876
77^511
978^573
11
G
SdG
NGdG
gdG
QX
e
e
WdG T
bdG T
WdG L
bdG L
G
dG Y dBG
Wd WdG dG jQCJ
fdG USGh ,WdG Yh d c 1985 Y Wd WdG dG fCG
G IQjR jCG J c .HEG P LQG G a a Jh ,G H dG j
eh dG c iNCG LG dG G) LG G G
.T c IMGh Ie dGh dN bGe IFGO AfEG e 1996 Y h .(FQ H
S j ,jG Z VGeCG aeh
a dG QN LY j jdG VG eCG
Wd LQG IOdG S Y gKCG AbG
JfH USG j M WdG Y c
G j c ,dM M LQG MG e
dG IFGO e QH G VG UJ Y
.dG IQGRd HdG QH
edG jjG e IFGdG g EG WdG

OGYEG c .IQGRdG Y GjH dG d
jRJh WdG M Y HEd IjL P
QgOREH NCG dG) WG e ac Y
SDG Y dch (cQG dG GS e
eh SHb dG eL e) dG
dG HEG ( dG P J h .(G dG Gb
M 2001 Y jQLEG WdG Y HEG UCG Y jRJh YWh (2 G fCG) 2000 Y
dM J j ea .4/2001 bQ QGRdG QGdG M Y HEH J CG j dG SDG ac
G dG e dG dG Y j WS e e KK J jCG c .WdG
dSQEGh HEG P H j GC G fdG L d Vd HQG WdG
iNCG SDG eCG .Wd WdG dG EG UG BG SG efH G dNOEGh gJh
.dH
dG eL eh G GdG c
.dG HEG GAGLEG f a SHb
fdG L -1
dG G (CG
dNOEGh bJh fdG J -2
M L J j c 2002 Y jf M dG dG e GQjR dG G j
UG VGeCd dG dG GSH WdG LQG fdG USGh dG SDG
edH (ICD-O2) dG QGUEG e WdH WdG Y ce IQjR Jh .WdG S P
j ch .(M) LdaQG edGh (C) GZHdG Le ce cG UH YSCG Je
12
dG Y dBG
dG G LG G e hGh
QGUEG) WdG S efH fdG NOEG
FGb SQEG j dG Gg eh .Wd WdG
WdG d dhdG dcdG b e G (ddG
g YJh .WG e e He
.fa ,d
jG Vh jh dG j FGdG
e HGdG QGUEG NOEG 2003 HcCG h
.(J hCG IG b Y)
dGh WdG d BG SG efH
WdG Ve Fb Y G j :dK ddG QGUEG WdH UG VGeCd dG

dG d LG d eOdG
fdG a Y IQdG efdG Gdh .(ICD-O3)
.FdG
e cCG dG J d IQe IQH NG
SQEH dG dG T GjO j :HGQ SGH ec fdG IYb a jh ,IMGh Ie

EG ,Y LY jdG VG H
b dPh
e VG ADH Fb Y G jh QG
a AGLEH efdG j c .dG Y AGLEG
.2002 Y
QdG be H fG d fdG d
(IARC-CHECK)
d NCG efH
j jdG fdG H gj :eN He ieh QdG a X dG fCGh G

GQeEG dhO CGJ e EG jOhG WG
.jG d
jh WdG Yh d IG HdG
fdG SG -3
.jS ADH Fb Y G
e YCG QOG c e IOG fdG UJ J e jGdG fdG Y G j :hCG

.QGSH dG j LCG LdKdG G H dG G ac
dG G) dG GQhCG J Gh
fdG - 4 SHb dG eh dG eh
efH GSH fdG JGh U a j SGH dPh (LG QU eh dH
dcdG b e Gh 1998 d BG SG dM J jdG VG jQJ e f
Vh QGSH j c ,WdG d dhdG CGH bh .WdH HUEG SSCG Y
dG efH GSH hGh jRd hGL jQJ SQEG SHb dG eL e
.2001 Y e e
WdG fH eCG .(HGdG dG)WdG
efH e SOdG dG EG `f `à jOdG NdG V jdG FGdG SQEG j :fK

13
dG Y dBG
jOe S dG o dG G I`` jG VGeCG aeh bGe ce e)
EPIINFO
e KdGh O`` G `` Mh `` jj `` e hCG `` e ) `` e (jeCG IG jdH ,fWCG ,LQH

VY cCG dG OY Y ee (jO dGh Gh G ah hG e d
.(dCG Fe d) IdG f HUEG Vh a WCG fWS Ff eCG .LdaQG
Y hG e g : dH hG e dG VG dG Yd ah
. e jY hGGh fdG SdG eCG .WCG fWd dG
kjQhV kGeCG dG Ije J : dG Ije e cCG aShje efH GSH Vh a
.Harvard Graphics aGL Oag efHh
NBG `` `` e `` h`` G `` e `` fQ
GSG j Gd ,jdG `` fdG cdG `` jdG YH) fS SGb Y G j

dPh ,( 3 h`` G ) dG d `` fdG `` cdG eGSG j dGh (bEH Gh GS N
KCdG `` e dGh `` G h`` G `` e `` jd .WdG ObG IQGRh e hG e M
hG `` e GSG `` dHh .`` d `` HG QGdG Vj eT dhL jdG Gg jh
(13h12) `` dhG `` VG `` d `` G `` dG Gd HUEG be ah WdG hM dch
.2010 -1998
j dG i`` NCG G e fQG `` Y `` VGZCG
e IQOdG `` J UNh d dG Q`` G `` a
jJ -5
Y WdG HC dhdG `` dcdGh dG `` dG
WdG hM `` e) eSG jQhdG `` JGQGUEG Y IjG WdG M OY g :hG

.e Ia IO fS
.( G GQdG
jJ `` KG jQdG g :dG ``jQJ
cEG d dH `` eCG .LdKdGh fCG
jG e Q`` G jQdG g `` dG jQJ E` à
.WdH HUEG EG J dG MG fH
``HUEG `` ``VG ``fdG ``YG
fdG `` WGG `` e `` jdG `` J `` g :``VH
.e fWH HUEd Hb jd jdG
`` WdG `` M O`` Y `` g :``G h``G `è
14
dG Y dBG
.dG jJ G ,d hdG S Q dG dG : (3 hL)
15
dG
jdG dG
12^000
10^000
9^000
9^000
8^000
8^000
6^000
6^000
6^000
6^000
5^000
4^000
4^000
3^000
2^000
2^000
100^000
04-00
09-05
14-10
19-15
24-20
29-25
34-30
39-35
44-40
49-45
54-50
59-55
64-60
69-65
74-70
+75
LEG
edG FdG
G M Y WdG M jRJ :4 hG
(%) dG
QGdG
92^31
7^69
100^00
876
73
949
fY
jaGh
LEG
e (4 hG) dM 949,2010 d Wd WdG dG LQG WdG LEG OdG H

423 fdG QcdG OY c ,dM 876 eh .jaGdG H (7^69) dM 73h fdG H (%92^31) dM 876
H h 0^93:1 fEG G QcdG e Hh ,4 hG (%51^71) 453 fdG fEG OY c H (%48^29)
Y dG Se Hh (%6^8) d`` M 60,dP hO a IY HGdG Y WCG H Y G G OY
.S 50 fEH fQe S57EG d QcdG Sh dP ``Jjh ,S 53 dG
d ah fdG H WdG M jRJ :5 hG

( % ) dG
QGdG
48^29
51^71
100^00
423
453
876
QcP
fEG
LEG
2010 Y N fdG H FdG fWdG
(fEGh QcP) fdG H FT fWS Y gCG :6hL

IjG G OY
QdG f
dG
122
67
edG LOg dG AGO
59
cdG
50
IG
44
iNG G fWS
41
ShdG IZ
40
ddG fG
40
ddG
35
bQdG IdG
(SCGdG) dG RG
30
QcdG H WS M 7 bdG Gg j *
16
edG FdG
QcdG fdG H FT fWS Y gCG :7hL
jG dG
IjG G OY
9^7
8^3
8^3
7^6
6^9
6^4
5^0
4^5
3^8
3^6
41
35
35
32
29
27
21
19
16
15
QdG f
ShdG IZ
edG LOgdG AGO
cdG
ddG fG
ddG
IG
iNCG G GQhCG
FdG
(SCGdG) dG RG
dG
fEG fdG H FT fWS Y gCG :8hL

jG dG
IjG G OY
25^4
7^7
7^3
7^1
5^3
5^1
5^1
3^3
3^3
3^3
115
35
33
32
24
23
23
15
15
15
17
QdG f
dG
MdG Y
bQdG IdG
edG LOgdG AGO
cdG
iNG G GQhCG
IG
G
G
MdG
edG FdG
fdG H FT fWS Y gCG :3 T
18
dCG Fe d hG e
19
(GdH) jdG dG
2010 d G H WdG hM e : 4 T
edG FdG
edG FdG
2010
%
75+ 70- 65- 60- 55- 50- 45- 40- 35- 30- 25- 20- 15- 10- 5- 0-74 -69 -64 -59 -54 -49 -44 -39 -34 -29 -24 -19 -14 -9 -4
20
Oe f Qh
edG FdG
2010
%
10
+75 -70 -65 -60 -55 -50 -45 -40 -35 -30 -25 -20 -15 -10 -5
74- 69- 64- 59- 54- 49- 44- 39- 34- 29- 24- 19- 14- 9
-0
4
21
Oe f Qh
edG FdG
2010
11
+75 -70 -65 -60 -55 -50 -45 -40 -35 -30 -25 -20 -15 -10 -5
74- 69- 64- 59- 54- 49- 44- 39- 34- 29- 24- 19- 14- 9
-0
4-
22
Oe f Qh
edG FdG
2010
12
+75 -70 -65
74- 69-
-60 -55 -50 -45 -40 -35 -30 -25 -20 -15 -10 -5 -0
64- 59- 54- 49- 44- 39- 34- 29- 24- 19- 14- 9- 4-
23
Oe f
edG FdG
2010
1998
13
24
Oe f Qh
edG FdG
2010 1998

14
25
Oe f Qh
edG FdG
2010- 1998
15
26
edG FdG
2010- 1998
16
27
Oe f Qh
edG FdG
17
28
dG WS
dG WS
LdG j CG G e dh ,dG AfCG L AdG H YT fWdG cCG e dG WS j
IMGh ICGeG EG EG SGQdG J h jS G WdG M LEG e % 10 WdG Gg h .jCG
jS IjG G OY Jj CG bG eh .JM e Ia H HUEd Ve GS K c H e
jGh .edG GdG J G J e % 60 e 2025 Y e 15 EG 2002 Y je 10 e
G hdG hO H hCG JG j dG WS CG cdH
dM 100 GM J jh AdG H YT cCG fWdG e jCG dG WS a dG eG
S 59 49 jdG dG Jh .AdG H WdG M LEG e % 22^4 f dGh jS IjL
.VG GH HUEd VJ dG cCG e
e g c eG dG GdG N e jGJ VG GH HUEG e CG FMEG Jh
,dG dG b ,dG QfG) e IG CG dG EG dP dG Lj Q h .18 hL
W QdGh G dG gCG Y AdG id YdG IOjR EG c .(NdG h G gdG hJ IOjR
e jj AdG H id G e M GSG EG c .SCG H IjL M cG EG ODj dG
.W H WdH HUEG MG
GdG M AdG id dG WS M gG : 18 hL
29
OdG
dG
58
74
77
73
63
95
95
97
105
106
105
115
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
30
WCG fWS
31
32
WCG fWS
dHh ,dP hO a S 14 Y WCG H dM 60 g 2010 Y Y e WS dM 876 H e

.G WdG M e %6^85
(fEGh QcP) fdG WCG H FdG fWdG gCG :19 hL

jG dG
G OY
IjG
25
11^7
6^7
6^7
6^7
15
7
4
4
4
WdG f
dG dG VHG
Y Y eQhCG Qh
Y ecQS
OG dG VHG
LOg AGO
(QcdG) fdG WCG H FdG fWdG gCG :20 hL

jG dG
G OY
IjG
19^4
11^1
8^3
5^6
5^6
7
4
3
2
2
WdG f
dG dG VHG
Y Y eQhCG Qh
OG dG VHG
LOg dG AGO
Yf ehQCG Qh
(fEG) fdG WCG H FdG fWdG gCG: 21 hL

jG dG
G OY
IjG
33^3
12^5
12^5
8^3
4^2
8
3
3
2
1
33
WdG f
dG dG VHG
LOg AGO
Y Y eQhCG Qh
Y ecQS
OG dG VHG
WCG fWS
9
7
2
2
2
-
3
3
-
14-10
1
1
-
2
2
-
5^9
2
1
1
4
2
2
-
4-0
11^3
0^0
0^0
5^6
0^0
0^0
0^0
11^3
5^6
0^0
5^6
0^0
0^0
33^9
22^6
8^5
0^0
0^0
2^8
12^1
0^0
6^0
0^0
0^0
0^0
0^0
12^1
6^0
0^0
6^0
0^0
0^0
36^2
24^1
9^0
0^0
0^0
3^0
4
2
-
4
2
-
12
8
3
1
1
1
-
2
-
3
2
1
14-10
1
1
-
4
-
4
3
1
-
9-5
4
4
-
2
-
5
3
2
-
4-0
(WCG fWd hdG dG) 2010 Y N (fCGh QcP) fdG WCG fWd QGdG jRdG :22 hL
25^5
19^9
5^7
0^0
0^0
2^8
3
3
-
2
2
-
22^5
17^5
5^0
0^0
0^0
2^5
8^5
8^5
0^0
0^0
0^0
0^0
1
1
-
4
4
-
7^5
7^5
0^0
0^0
0^0
0^0
3
1
1
1
12^1
12^1
0^0
8^5
2^8
0^0
0^0
2^8
0^0
2^8
11^3
11^3
0^0
2
2
-
7^5
2^5
0^0
0^0
2^5
0^0
2^5
-
0^0
0^0
6^0
6^0
0^0
0^0
0^0
0^0
5^6
5^6
0^0
0^0
3
3
1
1
1
1
-
3
3
1
1
1
1
-
8^5
8^5
0^0
2^8
2^8
2^8
2^8
0^0
0^0
7^5
7^5
0^0
2^5
2^5
2^5
2^5
0^0
0^0
34
WCG fWS
dG e d dG ch ,dG e f ;G G f*
S 14-0 Y e WCd eT IYCG dG Gg
35
36

Cancer Incidence in Oman 2010

Diunggah oleh

Informasi Dokumen

Hak Cipta

Format Tersedia

Bagikan dokumen Ini

Bagikan atau Tanam Dokumen

Opsi Berbagi

Apakah menurut Anda dokumen ini bermanfaat?

Apakah konten ini tidak pantas?

Hak Cipta:

Format Tersedia

Cancer Incidence in Oman 2010

Diunggah oleh

Hak Cipta:

Format Tersedia

Cancer Incidence in Oman

Cancer Incidence in Oman

Dr. Ali Jaffer Mohammed

Dr. Qasim Al Salmi

Dr. Ali Al Maashani

Dr. Mohammed Al-Balushi

Dr. Adil Al Ansari

Dr. Ali Al Adhawi

Dr. Mohammed Al-Farsi

Dr. Salim Al Abri

Dr. Jawahir Al Yazidi

Dr. John Idicula

Dr. Abdul Rahman Saifudeen

Dr. Ahmed Al Mandhari

Mr. Mohammed Al Maawali

Dr. Aqeed Ali Al Harthi

Mr. Al Aqied Sultan Yarub Al-Bus

Dr. Jolly Philip

Dr. Jerard Strong

Dr. Imam A.Imam

Ms. Jokha Al Rashdi

in the interior with the exception of higher

The Sultanate of Oman is located in

mountains and Dhofar Governorate, which

the southeastern corner of the Arabian

enjoy a moderate climate throughout the

Peninsula. It has a coastal line extending

almost 1,700 kilometers from the Strait

The Sultanate of Oman is administratively

the Republic of Yemen, overlooking three

divided into 9 Governorates/ Regions with

seas; the Arabian Gulf, Gulf of Oman and

61 Wilayah. These are: Muscat, Dhofar,

the Arabian Sea.

The country borders

Musandam and Buraimi Governorates

Saudi Arabia and United Arab Emirates

and regions of Ad Dakhliyah, Sharqiyah,

(UAE) in the west, the Republic of Yemen

Batinah, Adh Dhahirah, and Al Wusta. The

in the south, the Strait of Hormuz in the

regions of Sharqiyah and Batinah have

north and the Arabian Sea in the east.

each been further subdivided into two,

Besides, there are a number of scattered

for the purpose of health administration,

Omani islands in the Arabian Sea; the most

giving a total of ten health regions.

important are Masirah and Al-Halaniyat.

approximately 309,500 square kilometers

The estimated mid-year population in 2010

and it is the second largest country in

was 2,749,734 of which 1,933,591 were

the Arabian Peninsula. The Sultanate is

Omanis and 816,143 were Non-Omanis

composed of varying topographic areas

(Table 1). The Omani population shows a

consisting of plains, wadis (dry river beds)

sex ratio of 975 females per 1000 males.

and mountains. The most important area

About 13.46% of the population is under-5

is the plain overlooking the Gulf of Oman

years and 35.28% is under-15 years. Only

and the Arabian Sea with an area of about